{"id":24305,"date":"2024-10-03T05:06:39","date_gmt":"2024-10-03T05:06:39","guid":{"rendered":"https:\/\/digify.com\/?p=24305"},"modified":"2026-02-27T06:04:43","modified_gmt":"2026-02-27T06:04:43","slug":"biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security","status":"publish","type":"post","link":"https:\/\/staging-x.digifyteam.com\/tr\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/","title":{"rendered":"Biyoteknoloji Ba\u011f\u0131\u015f Toplama: Trendler, Zorluklar ve Veri G\u00fcvenli\u011finin Kritik Rol\u00fc"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"24305\" class=\"elementor elementor-24305\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5ed1446 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5ed1446\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f466aa0\" data-id=\"f466aa0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5cd4a60 elementor-widget elementor-widget-text-editor\" data-id=\"5cd4a60\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknoloji giri\u015fimleri, ileri d\u00fczey bilimin karma\u015f\u0131k i\u015f kararlar\u0131yla bulu\u015ftu\u011fu y\u00fcksek riskli bir ortamda faaliyet g\u00f6stermektedir. A Serisi finansman sa\u011flayan 10%'den daha az\u0131 ile, ke\u015fiften pazar onay\u0131na giden yolculuk, her bir geli\u015ftirme a\u015famas\u0131n\u0131 do\u011fru zamanda do\u011fru finansal destekle y\u00f6nlendirmekle ilgilidir.<sup>1<\/sup><\/p><p>Erken ke\u015fif a\u015famas\u0131nda, \u00f6ny\u00fckleme ve melek yat\u0131r\u0131mlar ara\u015ft\u0131rman\u0131z\u0131 ba\u015flatmak i\u00e7in \u00e7ok \u00f6nemli olabilir. Klinik \u00f6ncesi denemelerde ilerledik\u00e7e, kavram\u0131n kan\u0131t\u0131n\u0131 g\u00f6stermek ve umut verici tedaviler geli\u015ftirmek i\u00e7in tohum finansman\u0131 sa\u011flamak hayati \u00f6nem kazan\u0131r. Maliyetlerin h\u0131zla artabilece\u011fi klinik deneylere ge\u00e7ti\u011finizde, yeni ila\u00e7lar\u0131n veya tedavilerin geli\u015ftirilmesini ve test edilmesini finanse etmek i\u00e7in A ve B Serisi turlar gereklidir. Bir \u00fcr\u00fcn\u00fc pazara sunmak gibi daha sonraki a\u015famalarda, \u00fcretimi \u00f6l\u00e7eklendirmek ve d\u00fczenleyici engelleri y\u00f6netmek i\u00e7in C Serisi finansman gerekebilir.<\/p><p>Ancak yat\u0131r\u0131mc\u0131lar\u0131 \u00e7ekmek, \u00e7\u0131\u011f\u0131r a\u00e7an bir bilime sahip olman\u0131n \u00f6tesine ge\u00e7mektedir. Fikri m\u00fclkiyetin (IP) korunmas\u0131 kritik \u00f6nem ta\u015f\u0131r ve biyoteknoloji giri\u015fimleri ticari s\u0131rlar\u0131n patentlere kar\u015f\u0131 avantajlar\u0131n\u0131 dikkatle tartmal\u0131d\u0131r. Patentler s\u0131n\u0131rl\u0131 bir s\u00fcre i\u00e7in kamusal koruma sunarken, \u00e7\u00f6z\u00fcm\u00fcn\u00fczle ilgili ayr\u0131nt\u0131lar\u0131 da if\u015fa eder. Ayr\u0131ca korunmas\u0131 i\u00e7in \u00f6nemli kaynaklar gerektirir.<\/p><p>\u00d6te yandan, ticari s\u0131rlar tescilli bilgilerinizi gizli tutman\u0131za olanak tan\u0131r, ancak s\u0131zd\u0131r\u0131lmas\u0131 veya \u00e7al\u0131nmas\u0131 durumunda yasal koruma olmaks\u0131z\u0131n a\u00e7\u0131\u011fa \u00e7\u0131kma riskini de beraberinde getirir. Yat\u0131r\u0131mc\u0131lar fikri m\u00fclkiyet stratejinizi yak\u0131ndan de\u011ferlendirecektir, \u00e7\u00fcnk\u00fc patentlerin ne zaman ba\u015fvurulaca\u011f\u0131 ve etkinle\u015ftirilece\u011fi zamanlamas\u0131 uzun vadeli rekabet g\u00fcc\u00fcn\u00fcz\u00fc \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/p><p>Veri g\u00fcvenli\u011fi, \u015firketiniz geli\u015fim a\u015famalar\u0131nda ilerledik\u00e7e ba\u011f\u0131\u015f toplama yolculu\u011funuzun hayati bir y\u00f6n\u00fc haline gelir. Yat\u0131r\u0131mc\u0131lar, ister patentli olsun ister ticari s\u0131r olarak saklans\u0131n, hassas ara\u015ft\u0131rmalar\u0131n\u0131z\u0131n, hasta verilerinizin ve fikri m\u00fclkiyetinizin ihlallere kar\u015f\u0131 korundu\u011funa dair g\u00fcvence ister. Tek bir g\u00fcvenlik ihlali, verilerinizi ve yat\u0131r\u0131mc\u0131larla ve ortaklarla kurdu\u011funuz g\u00fcveni tehlikeye atabilir, klinik ilerlemeyi ve uzun vadeli ortakl\u0131klar\u0131 potansiyel olarak durdurabilir.<\/p><p>Bu makalede, biyoteknoloji alan\u0131nda kaynak yaratma konusundaki temel e\u011filimleri, geli\u015ftirmenin her a\u015famas\u0131ndaki benzersiz zorluklar\u0131n nas\u0131l a\u015f\u0131laca\u011f\u0131n\u0131 ve fikri m\u00fclkiyet korumas\u0131 ve veri g\u00fcvenli\u011fi ile ilgili kararlar\u0131n yat\u0131r\u0131mc\u0131 g\u00fcvenini kazanma ve korumada nas\u0131l \u00e7ok \u00f6nemli hale geldi\u011fini ke\u015ffedeceksiniz. Bu unsurlarda ustala\u015farak, biyoteknoloji giri\u015fiminizi son derece rekabet\u00e7i bir alanda \u00f6ne \u00e7\u0131kacak \u015fekilde konumland\u0131rabilirsiniz.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b277780 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b277780\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f08282a\" data-id=\"f08282a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4a01a8d elementor-widget elementor-widget-text-editor\" data-id=\"4a01a8d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>\u0130\u00e7indekiler<\/h3>\n<ul>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=4%20Current%20Trends%20Shaping%20Biotech%20Fundraising%20in%202024\" target=\"_blank\" rel=\"noopener\">2024'te Biyoteknoloji Alan\u0131nda Kaynak Yaratmay\u0131 \u015eekillendiren G\u00fcncel E\u011filimler<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=4%20Emerging%20Trends%20in%20Biotech%20Fundraising%20You%20Need%20to%20Know\" target=\"_blank\" rel=\"noopener\">Biyoteknoloji Kaynak Geli\u015ftirme Alan\u0131nda Bilmeniz Gereken Yeni Trendler\n<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Venture%20Capitalist%20Perspectives%3A%20What%20Biotech%20Investors%20Are%20Looking%20For\" target=\"_blank\" rel=\"noopener\">Giri\u015fim Sermayesi Perspektifleri\n<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Overcoming%20Fundraising%20Challenges%20for%20Biotech%20Startups\" target=\"_blank\" rel=\"noopener\">Kaynak Yaratma Zorluklar\u0131n\u0131n \u00dcstesinden Gelme<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=The%20Crucial%20Role%20of%20Data%20Security%20in%20Biotech%20Fundraising\" target=\"_blank\" rel=\"noopener\">Biyoteknoloji Ba\u011f\u0131\u015f Toplama S\u00fcrecinde Veri G\u00fcvenli\u011fi<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Due%20Diligence%20Checklist%3A%20How%20Biotech%20Startups%20Can%20Secure%20Investor%20Funding\" target=\"_blank\" rel=\"noopener\">Durum Tespiti Kontrol Listesi<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Regional%20Breakdown%3A%20North%20America%2C%20Europe%2C%20and%20APAC\" target=\"_blank\" rel=\"noopener\">B\u00f6lgesel Da\u011f\u0131l\u0131m\n<\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Key%20Takeaways%20and%20Strategic%20Recommendations\" target=\"_blank\" rel=\"noopener\">Temel \u00c7\u0131kar\u0131mlar ve Tavsiyeler <\/a><\/li>\n \t<li><a href=\"https:\/\/digify.com\/blog\/biotech-fundraising-navigating-trends-challenges-and-the-critical-role-of-data-security\/#:~:text=Elevating%20Your%20Biotech%20Fundraising%20Strategy%3A%20The%20Power%20of%20Data%20Security\" target=\"_blank\" rel=\"noopener\">Biyoteknoloji Ba\u011f\u0131\u015f Toplama Stratejinizi Geli\u015ftirin<\/a><\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1a98d29 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1a98d29\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-0228207\" data-id=\"0228207\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b82d684 elementor-widget elementor-widget-heading\" data-id=\"b82d684\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2>4 2024 Y\u0131l\u0131nda Biyoteknoloji Alan\u0131nda Kaynak Yaratmay\u0131 \u015eekillendiren G\u00fcncel Trendler<\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9755923 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9755923\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6d818cf\" data-id=\"6d818cf\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7dc8d18 elementor-widget elementor-widget-text-editor\" data-id=\"7dc8d18\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknoloji h\u0131zla geli\u015fiyor ve sekt\u00f6r\u00fc besleyen finansman dinamikleri de de\u011fi\u015fiyor. Geli\u015fen teknolojiler geleneksel sa\u011fl\u0131k hizmeti modellerini alt\u00fcst ederken, do\u011fru yat\u0131r\u0131m\u0131 almak biyoteknoloji giri\u015fimleri i\u00e7in hem bir zorluk hem de bir f\u0131rsat haline geldi.\u00a0<\/p><p>Bu trendleri anlamak, \u015firketinizi bu rekabet\u00e7i ortamda \u00f6n s\u0131ralarda konumland\u0131rmak i\u00e7in \u00e7ok \u00f6nemlidir. \u0130\u015fte 2024 y\u0131l\u0131nda biyoteknoloji alan\u0131nda kaynak yaratmay\u0131 yeniden tan\u0131mlayan d\u00f6rt ana trend:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d050067 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d050067\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-60aa79e\" data-id=\"60aa79e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-268d37b elementor-widget elementor-widget-text-editor\" data-id=\"268d37b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"font-family: Ubuntu, sans-serif; color: #303030;\">#1 - Tarihi Bir Yat\u0131r\u0131m Dalgalanmas\u0131<\/h3><p>Biyoteknoloji, ABD ve Avrupa'daki yat\u0131r\u0131mlar\u0131n 2024 ortas\u0131na kadar $6,8 milyar VC fonu toplamas\u0131yla rekor d\u00fczeyde bir sermaye ak\u0131\u015f\u0131 ya\u015f\u0131yor.<sup>2<\/sup> CRISPR teknolojisi, sentetik biyoloji gibi geli\u015fmeler ve yat\u0131r\u0131mc\u0131lar\u0131n sekt\u00f6r\u00fcn uzun vadeli potansiyeline olan g\u00fcveni bu art\u0131\u015f\u0131 tetikliyor.<\/p><p>Biyoteknolojiye fon sa\u011flayanlar giderek geni\u015fliyor. Geleneksel giri\u015fim sermayesinin yan\u0131 s\u0131ra, kurumsal giri\u015fim kollar\u0131 ve y\u00fcksek net de\u011ferli aile ofisleri de oyuna dahil oluyor ve biyoteknoloji end\u00fcstrisinden yararlanmak isteyen yat\u0131r\u0131mc\u0131 havuzunu \u00e7e\u015fitlendiriyor. Yeni ba\u015flayanlar i\u00e7in bu, cesur ve y\u00fcksek etkili fikirler sunmak i\u00e7in hi\u00e7 bu kadar iyi bir zaman olmad\u0131\u011f\u0131 anlam\u0131na geliyor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b406396 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b406396\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e87ee74\" data-id=\"e87ee74\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9a46ef0 elementor-widget elementor-widget-text-editor\" data-id=\"9a46ef0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3 style=\"font-family: Ubuntu, sans-serif; color: #303030;\">#2 - Giri\u015fim Sermayesi Hala \u00d6nde, Ama Bir De\u011fi\u015fiklikle<\/h3><p>Risk sermayesi (VC), biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n yakla\u015f\u0131k 65%'sine katk\u0131da bulunarak bask\u0131n olmaya devam etmektedir.<sup>3<\/sup> Bununla birlikte, odak noktas\u0131nda bir de\u011fi\u015fim var -VC firmalar\u0131 art\u0131k biyom\u00fchendislik ve yeni nesil gen terapileri gibi daha riskli, \u00e7\u0131\u011f\u0131r a\u00e7an teknolojileri hedefliyor.<\/p><p>2024'teki temel fark nedir? Risk sermayedarlar\u0131 ila\u00e7 ke\u015ffinin \u00f6tesine bak\u0131yor. Biyoteknoloji giri\u015fimlerinin tekliflerini \u00e7e\u015fitlendirmesine ve yat\u0131r\u0131mc\u0131 \u00e7ekicili\u011fini en \u00fcst d\u00fczeye \u00e7\u0131karmas\u0131na olanak tan\u0131yan yapay zeka tabanl\u0131 ara\u015ft\u0131rma ara\u00e7lar\u0131 gibi sa\u011fl\u0131k hizmetleri genelinde birden fazla uygulamaya hizmet edebilecek platform teknolojilerini ikiye katl\u0131yorlar.<\/p><p>Yeni ba\u015flayanlar i\u00e7in, sekt\u00f6r\u00fcn ihtiya\u00e7lar\u0131na g\u00f6re geli\u015febilen \u00e7ok y\u00f6nl\u00fc bir teknoloji sunmak, erken a\u015fama finansman sa\u011flama \u015fans\u0131n\u0131z\u0131 art\u0131rabilir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7911b68 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7911b68\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e16375e\" data-id=\"e16375e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f3b9c18 elementor-widget elementor-widget-text-editor\" data-id=\"f3b9c18\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#3 - Devlet ve \u00d6zel Sermaye: Muhtemel Olmayan M\u00fcttefikler<\/h3><p>2024 y\u0131l\u0131nda, devlet hibeleri ve \u00f6zel sermaye (PE) aras\u0131ndaki i\u015fbirli\u011fi biyoteknoloji fonlar\u0131n\u0131 yeniden \u015fekillendiriyor. Geleneksel olarak devlet hibeleri, pandemiye haz\u0131rl\u0131k ve antimikrobiyal diren\u00e7 gibi \u00f6nemli alanlar\u0131 destekleyen erken a\u015fama ara\u015ft\u0131rmalar\u0131n temel ta\u015f\u0131 olmu\u015ftur. \u015eimdi ise \u00f6zel sermaye, b\u00fcy\u00fcmeye haz\u0131r sonraki a\u015fama biyoteknoloji \u015firketlerine odaklanarak rol\u00fcn\u00fc art\u0131r\u0131yor.<\/p><p>Bu y\u0131l\u0131n ay\u0131rt edici \u00f6zelli\u011fi, devlet destekli giri\u015fimler ile \u00f6zel sermaye yat\u0131r\u0131mlar\u0131 aras\u0131ndaki stratejik uyum. \u00d6zel sermaye \u015firketleri art\u0131k \u00f6l\u00e7eklenmeye haz\u0131r ancak sa\u011flam ticarile\u015ftirme stratejilerinden yoksun olabilecek kan\u0131tlanm\u0131\u015f teknolojilere sahip orta \u00f6l\u00e7ekli biyoteknoloji \u015firketlerini hedefliyor. Bu i\u015fbirli\u011fi, devlet deste\u011fi ile \u00f6zel sekt\u00f6r\u00fcn itici g\u00fcc\u00fcn\u00fc birle\u015ftiren g\u00fc\u00e7l\u00fc bir finansman melezi yarat\u0131yor.<\/p><p>Biyoteknoloji giri\u015fimleri i\u00e7in bu benzersiz bir f\u0131rsat sunuyor. Yenilik\u00e7ili\u011finizi, \u00f6l\u00e7eklenebilirli\u011finizi ve pazar potansiyelinizi g\u00f6stererek kamu ve \u00f6zel sekt\u00f6r \u00e7\u0131karlar\u0131n\u0131 harmanlayan bu hibrit finansman kaynaklar\u0131n\u0131 \u00e7ekebilirsiniz. \u015eirketinizi bu ikili finansman yollar\u0131yla uyumlu hale getirmek, projelerinizi ilerletmek i\u00e7in gereken sermayeyi elde etme olas\u0131l\u0131\u011f\u0131n\u0131z\u0131 b\u00fcy\u00fck \u00f6l\u00e7\u00fcde art\u0131rabilir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3e5858a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3e5858a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3cf377f\" data-id=\"3cf377f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9cbd679 elementor-widget elementor-widget-text-editor\" data-id=\"9cbd679\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#4 - Yat\u0131r\u0131m De\u011fi\u015fimleri: Onkolojiden MedTech ve Hassas T\u0131bba<\/h3><p>Onkoloji ve ila\u00e7 geli\u015ftirme biyoteknoloji yat\u0131r\u0131mlar\u0131na hakim olmaya devam etse de, MedTech ve hassas t\u0131bba do\u011fru g\u00f6zle g\u00f6r\u00fcl\u00fcr bir y\u00f6neli\u015f var.<sup>4<\/sup> Yapay zekay\u0131 te\u015fhis, erken hastal\u0131k tespiti ve tedavi planlamas\u0131na entegre eden teknolojiler b\u00fcy\u00fck ilgi g\u00f6r\u00fcyor ve bu alanlardaki fonlar ge\u00e7ti\u011fimiz y\u0131l iki kat\u0131na \u00e7\u0131kt\u0131.<\/p><p>S\u0131cak hedefler aras\u0131nda s\u0131v\u0131 biyopsi platformlar\u0131, yapay zeka odakl\u0131 g\u00f6r\u00fcnt\u00fcleme ve ultra ki\u015fiselle\u015ftirilmi\u015f tedaviye olanak tan\u0131yan genomik ara\u00e7lar yer al\u0131yor. Yat\u0131r\u0131mc\u0131lar, daha erken ve daha do\u011fru m\u00fcdahaleler vaat eden veri merkezli sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri geli\u015ftiren giri\u015fimlere giderek daha fazla ilgi duyuyor. MedTech ve hassas t\u0131bba odaklanan biyoteknoloji \u015firketleri i\u00e7in \u015fimdi spot \u0131\u015f\u0131klar\u0131n\u0131 yakalama zaman\u0131 - bu sekt\u00f6rler bir\u00e7ok ki\u015finin bekledi\u011finden daha h\u0131zl\u0131 ilgi g\u00f6r\u00fcyor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8f43b51 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8f43b51\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4166528\" data-id=\"4166528\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4fe5825 elementor-widget elementor-widget-heading\" data-id=\"4fe5825\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Biyoteknoloji Kaynak Geli\u015ftirme Alan\u0131nda Bilmeniz Gereken 4 Yeni Trend <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1ed956d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1ed956d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-863ac14\" data-id=\"863ac14\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d25d4f0 elementor-widget elementor-widget-text-editor\" data-id=\"d25d4f0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknoloji d\u00fcnyas\u0131 geli\u015ftik\u00e7e, fon yaratma e\u011filimleri de yeni teknolojilere, yat\u0131r\u0131mc\u0131 \u00f6nceliklerine ve sekt\u00f6rdeki zorluklara g\u00f6re de\u011fi\u015fiyor. Biyoteknoloji giri\u015fimleri i\u00e7in bu trendlerin bir ad\u0131m \u00f6n\u00fcnde olmak, finansman sa\u011flamak ve \u015firketinizi bu rekabet\u00e7i alanda lider olarak konumland\u0131rmak i\u00e7in \u00e7ok \u00f6nemlidir.<\/p><p>\u0130\u015fte biyoteknoloji alan\u0131nda kaynak yaratman\u0131n gelece\u011fini \u015fekillendiren ve bilmeniz gereken d\u00f6rt yeni trend:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6b0ec4f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6b0ec4f\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9064a02\" data-id=\"9064a02\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-63b1923 elementor-widget elementor-widget-text-editor\" data-id=\"63b1923\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#1 Mikro-VC'ler ve Hiper Odakl\u0131 Melek Yat\u0131r\u0131mc\u0131lar<\/h3><p>B\u00fcy\u00fck risk sermayesi \u015firketleri tarihsel olarak biyoteknoloji finansman\u0131na hakim olsa da, belirli ni\u015flerde uzmanla\u015fm\u0131\u015f mikro-VC'ler ve melek yat\u0131r\u0131mc\u0131lar giderek artmaktad\u0131r. Bu daha k\u00fc\u00e7\u00fck, hiper odakl\u0131 fonlar sentetik biyoloji, n\u00f6roteknoloji ve yeni nesil gen terapileri gibi geli\u015fmekte olan alanlar\u0131 hedeflemektedir. Geleneksel b\u00fcy\u00fck hitleri aramak yerine, ana ak\u0131m yat\u0131r\u0131mc\u0131lar\u0131n radar\u0131nda olmayabilecek uzun vadeli, vizyoner projelere y\u00f6neliyorlar.<\/p><p>Biyoteknoloji giri\u015fimleri i\u00e7in bu, ni\u015f vizyonunuzu payla\u015fan ve sa\u011fl\u0131k hizmetlerini d\u00f6n\u00fc\u015ft\u00fcrme potansiyeline sahip al\u0131\u015f\u0131lmad\u0131k at\u0131l\u0131mlar\u0131 desteklemeye istekli yat\u0131r\u0131mc\u0131larla uyum sa\u011flayarak erken a\u015fama finansman\u0131 \u00e7ekmek i\u00e7in daha fazla f\u0131rsat anlam\u0131na geliyor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ddcae4d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ddcae4d\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ce43bf0\" data-id=\"ce43bf0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6df80f4 elementor-widget elementor-widget-text-editor\" data-id=\"6df80f4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#2 Blok Zinciri ve Tokenizasyon Yoluyla Merkezi Olmayan Kaynak Yaratma<\/h3><p>Biyoteknoloji alan\u0131nda daha az bilinen ancak h\u0131zla y\u00fckselen bir trend, sermaye art\u0131r\u0131m\u0131 i\u00e7in merkezi olmayan platformlar olu\u015fturmak \u00fczere blok zinciri ve tokenle\u015ftirmedir. Bu platformlar, giri\u015fimlerin geleneksel kap\u0131 bek\u00e7ilerini atlamas\u0131na ve do\u011frudan k\u00fcresel bir yat\u0131r\u0131mc\u0131 havuzundan fon toplamas\u0131na olanak tan\u0131r.\u00a0<\/p><p>\u00d6zellikle tokenize hisse senedi teklifleri, daha geni\u015f bir yat\u0131r\u0131mc\u0131 yelpazesine hitap edebilecek k\u0131smi sahiplik ve likiditeye izin verdi\u011fi i\u00e7in ilgi g\u00f6rmektedir. Hen\u00fcz emekleme a\u015famas\u0131nda olan bu y\u00f6ntem, biyoteknoloji giri\u015fimlerinin finansman sa\u011flama \u015feklini yeniden \u015fekillendirebilir, sermaye art\u0131r\u0131m\u0131na daha demokratikle\u015ftirilmi\u015f bir yakla\u015f\u0131m sunabilir ve \u00e7e\u015fitli ve teknoloji merakl\u0131s\u0131 bir yat\u0131r\u0131mc\u0131 taban\u0131yla etkile\u015fim kurmak i\u00e7in yeni f\u0131rsatlar yaratabilir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6f1eb1e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6f1eb1e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6d76647\" data-id=\"6d76647\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c5767b2 elementor-widget elementor-widget-text-editor\" data-id=\"c5767b2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#3 S\u00fcrd\u00fcr\u00fclebilirlik Ba\u011flant\u0131l\u0131 Finansman<\/h3><p>S\u00fcrd\u00fcr\u00fclebilirlik, biyoteknoloji giri\u015fimlerinin yat\u0131r\u0131mc\u0131lar taraf\u0131ndan de\u011ferlendirilmesinde \u00e7ok \u00f6nemli bir fakt\u00f6r haline geliyor. Ancak burada i\u015fler ilgin\u00e7le\u015fiyor: Sadece \u00e7evresel faydalara odaklanmak yerine, baz\u0131 yat\u0131r\u0131mc\u0131lar s\u00fcrd\u00fcr\u00fclebilirlik ba\u011flant\u0131l\u0131 krediler veya \u015firketleri \u00f6nemli \u00e7evresel, sosyal ve y\u00f6neti\u015fim (ESG) kilometre ta\u015flar\u0131na ula\u015ft\u0131klar\u0131 i\u00e7in \u00f6d\u00fcllendiren finansman yap\u0131lar\u0131 sunuyor.<\/p><p>Ye\u015fil kimya, biyo-imalat veya karbon yakalama gibi sekt\u00f6rlerde \u00e7al\u0131\u015fan biyoteknoloji \u015firketleri i\u00e7in bu, uzun vadeli b\u00fcy\u00fcmeyi etkili s\u00fcrd\u00fcr\u00fclebilirlik sonu\u00e7lar\u0131yla uyumlu hale getiren ve ESG hedeflerine ula\u015fmak i\u00e7in finansal te\u015fvikler sunan yeni bir kaynak yaratma bi\u00e7iminin \u00f6n\u00fcn\u00fc a\u00e7\u0131yor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-93440ef elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"93440ef\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7c023e4\" data-id=\"7c023e4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0cb2d1f elementor-widget elementor-widget-text-editor\" data-id=\"0cb2d1f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>#4 Ki\u015fiselle\u015ftirilmi\u015f T\u0131p ve Veriden Para Kazanma Modelleri<\/h3><p>Yapay zeka ve makine \u00f6\u011frenimi biyoteknolojiyle ilgili tart\u0131\u015fmalara \u00f6nc\u00fcl\u00fck ederken, daha az ke\u015ffedilmi\u015f bir yol, giri\u015fimlerin verilerden yeni yollarla para kazanmak i\u00e7in bu teknolojilerden nas\u0131l yararland\u0131klar\u0131d\u0131r. Ki\u015fiselle\u015ftirilmi\u015f t\u0131p alan\u0131ndaki biyoteknoloji firmalar\u0131, hasta ve genomik verileri bir gelir ak\u0131\u015f\u0131 olarak kullanmak i\u00e7in hastaneler, ila\u00e7 \u015firketleri ve ara\u015ft\u0131rma kurumlar\u0131yla ortakl\u0131k kurarak benzersiz veri para kazanma modelleri sunuyor.<\/p><p>Bu e\u011filim, verilerin ila\u00e7 ke\u015ffi i\u00e7in bir ara\u00e7 ve yat\u0131r\u0131m ve stratejik ortakl\u0131klar\u0131 \u00e7eken kazan\u00e7l\u0131 bir varl\u0131k haline geldi\u011fi erken a\u015fama biyoteknoloji \u015firketleri i\u00e7in oyunun kurallar\u0131n\u0131 de\u011fi\u015ftirebilir.\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0da8d59 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0da8d59\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-eea4645\" data-id=\"eea4645\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a968c2d elementor-widget elementor-widget-heading\" data-id=\"a968c2d\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Risk Sermayecisi Perspektifleri: Biyoteknoloji Yat\u0131r\u0131mc\u0131lar\u0131 Ne Ar\u0131yor? <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8e97422 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8e97422\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f6d5869\" data-id=\"f6d5869\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-dd93c7a elementor-widget elementor-widget-text-editor\" data-id=\"dd93c7a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknolojinin son derece rekabet\u00e7i ortam\u0131nda, risk sermayesi finansman\u0131n\u0131 g\u00fcvence alt\u0131na almak ileri bilimden daha fazlas\u0131n\u0131 gerektirir; yat\u0131r\u0131mc\u0131lar\u0131n en \u00e7ok \u00f6ncelik verdi\u011fi \u015feylerle stratejik uyum gerektirir. \u0130\u015fte risk sermayedarlar\u0131n\u0131n biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131 de\u011ferlendirirken veri g\u00fcvenli\u011fi \u00f6nlemlerinden inovasyon ve ticarile\u015ftirme potansiyelinin m\u00fckemmel kar\u0131\u015f\u0131m\u0131na kadar arad\u0131\u011f\u0131 \u00f6zellikler.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-645cfae elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"645cfae\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-51e297f\" data-id=\"51e297f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6f066d4 elementor-widget elementor-widget-text-editor\" data-id=\"6f066d4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Veri G\u00fcvenli\u011fi: Yeni Olmazsa Olmaz<\/h3><p>D\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc bilim art\u0131k tek ba\u015f\u0131na giri\u015fiminizin finanse edilmesini sa\u011flam\u0131yor; giri\u015fim sermayedarlar\u0131 veri g\u00fcvenli\u011fine odaklanm\u0131\u015f durumda. Veri g\u00fcvenli\u011fi, biyoteknoloji yat\u0131r\u0131m kararlar\u0131nda giderek daha kritik bir fakt\u00f6r olarak kabul ediliyor.\u00a0<\/p><p>Biyoteknoloji \u015firketleri hassas ara\u015ft\u0131rma ve ki\u015fisel sa\u011fl\u0131k verilerini i\u015fledi\u011finden, risk sermayedarlar\u0131 \u00f6zellikle g\u00fc\u00e7l\u00fc veri y\u00f6neti\u015fimi ve fikri m\u00fclkiyet korumas\u0131 sergileyen \u015firketlerle ilgilenmektedir.\u00a0<\/p><p>Dijital tehditlerin artmas\u0131 ve hassas fikri m\u00fclkiyetin tehlikede olmas\u0131 nedeniyle yat\u0131r\u0131mc\u0131lar, \u015firketinizin ara\u015ft\u0131rma verilerini, hasta bilgilerini ve \u00f6zel s\u00fcre\u00e7leri g\u00fcvence alt\u0131na almak i\u00e7in sa\u011flam politikalara sahip oldu\u011funu bilmek ister.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-342a787 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"342a787\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bcadbbd\" data-id=\"bcadbbd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fb1bc6d elementor-blockquote--skin-border elementor-widget elementor-widget-blockquote\" data-id=\"fb1bc6d\" data-element_type=\"widget\" data-widget_type=\"blockquote.default\">\n\t\t\t\t\t\t\t<blockquote class=\"elementor-blockquote\">\n\t\t\t<p class=\"elementor-blockquote__content\">\n\t\t\t\t\u201cGer\u00e7ekte, daha g\u00fc\u00e7l\u00fc fikri m\u00fclkiyet korumas\u0131 ila\u00e7 ara\u015ft\u0131rmalar\u0131n\u0131 te\u015fvik eder ve patent sahiplerinin t\u0131bbi bulu\u015flar\u0131 d\u00fcnya \u00e7ap\u0131nda payla\u015fmas\u0131n\u0131 sa\u011flar.\u201d<sup>5<\/sup><span style=\"background-color: transparent;color: var( --e-global-color-text )\"><\/span>\t\t\t<\/p>\n\t\t\t\t\t\t\t<div class=\"e-q-footer\">\n\t\t\t\t\t\t\t\t\t\t\t<cite class=\"elementor-blockquote__author\">Hans Sauer, Fikri M\u00fclkiyetten Sorumlu Ba\u015fkan Yard\u0131mc\u0131s\u0131<br>Biyoteknoloji \u0130novasyon Organizasyonu (BIO)<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6b74a6f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6b74a6f\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b54c7c0\" data-id=\"b54c7c0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-b894850 elementor-widget elementor-widget-text-editor\" data-id=\"b894850\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Startup'lar\u0131 di\u011ferlerinden ay\u0131ran nedir? Net veri y\u00f6netimi \u00e7er\u00e7eveleri ve en son siber g\u00fcvenlik standartlar\u0131na uyum. Yat\u0131r\u0131mc\u0131lar sadece yeni tedaviler aram\u0131yor; ayn\u0131 zamanda at\u0131l\u0131mlar\u0131n\u0131z\u0131n ilerlemenizi raydan \u00e7\u0131karabilecek s\u0131z\u0131nt\u0131lardan veya ihlallerden korundu\u011funa dair g\u00fcvence istiyorlar. Biyoteknoloji startup'lar\u0131 i\u00e7in, verilerin korunmas\u0131na y\u00f6nelik kapsaml\u0131 bir yakla\u015f\u0131m sergilemek, sat\u0131\u015f konu\u015fman\u0131z\u0131 yapabilir veya bozabilir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7fe90c6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7fe90c6\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4c39998\" data-id=\"4c39998\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0511505 elementor-widget elementor-widget-text-editor\" data-id=\"0511505\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Pazardaki Bo\u015fluklar\u0131 Dolduran \u0130novasyon<\/h3><p>Risk sermayedarlar\u0131 her zaman bir sonraki b\u00fcy\u00fck \u015feyin aray\u0131\u015f\u0131ndad\u0131r; ancak \u00f6zellikle kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 ele alan veya mevcut tedaviler \u00fczerinde d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc iyile\u015ftirmeler sunan yenilikler aramaktad\u0131rlar. Art\u0131ml\u0131 ilerlemeler art\u0131k yeterli de\u011fil. Sa\u011fl\u0131k hizmetlerini ilerletebilecek y\u00fcksek riskli, y\u00fcksek \u00f6d\u00fcll\u00fc projeler sunan giri\u015fimler yat\u0131r\u0131m\u0131n ana pay\u0131n\u0131 al\u0131yor.<\/p><p>Ancak i\u015fin p\u00fcf noktas\u0131 \u015fu: mesele sadece bilimsel m\u00fckemmellik de\u011fil. Yat\u0131r\u0131mc\u0131lar ayr\u0131ca ticarile\u015ftirmeye giden a\u00e7\u0131k ve uygulanabilir bir yol g\u00f6rmek isterler. Pazara giri\u015f i\u00e7in bir yol haritas\u0131 olmayan \u00e7\u0131\u011f\u0131r a\u00e7an yenilikler genellikle ilgi \u00e7ekmekte zorlan\u0131r. Risk sermayedarlar\u0131, ileri teknolojilerini iyi yap\u0131land\u0131r\u0131lm\u0131\u015f bir i\u015f stratejisiyle e\u015fle\u015ftiren giri\u015fimlere y\u00f6nelirler. Biyoteknoloji kurucular\u0131 i\u00e7in bu, giri\u015fiminizi bir yenilik\u00e7i ve ticarile\u015ftirme labirentinde gezinebilecek bir \u015firket olarak konumland\u0131rmak anlam\u0131na gelir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f69f2d6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f69f2d6\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-18dea32\" data-id=\"18dea32\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6f13c83 elementor-blockquote--skin-border elementor-widget elementor-widget-blockquote\" data-id=\"6f13c83\" data-element_type=\"widget\" data-widget_type=\"blockquote.default\">\n\t\t\t\t\t\t\t<blockquote class=\"elementor-blockquote\">\n\t\t\t<p class=\"elementor-blockquote__content\">\n\t\t\t\t\u201cErken a\u015fama biyoteknoloji CEO'lar\u0131 elbette her zaman bilim insan\u0131 olmak zorunda de\u011fildir, ancak neredeyse t\u00fcm biyoteknoloji \u015firketlerinin g\u00fc\u00e7l\u00fc bir bilimsel liderli\u011fe sahip olmas\u0131 ve bunu k\u00fclt\u00fcr\u00fcn merkezi olarak benimsemesi gerekir. Tekrarlanabilir, y\u00fcksek kaliteli bilim ve bilimsel y\u00f6ntemin objektifli\u011fi uzun vadeli ba\u015far\u0131n\u0131n temel ta\u015flar\u0131d\u0131r.\u201d<sup>6<\/sup>\t\t\t<\/p>\n\t\t\t\t\t\t\t<div class=\"e-q-footer\">\n\t\t\t\t\t\t\t\t\t\t\t<cite class=\"elementor-blockquote__author\">Bruce Booth, Ortak<br>Atlas Giri\u015fim<\/cite>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-28fce19 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"28fce19\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e1a83a8\" data-id=\"e1a83a8\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f8c2ddc elementor-widget elementor-widget-text-editor\" data-id=\"f8c2ddc\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>G\u00fc\u00e7l\u00fc Ortakl\u0131klar Yoluyla Ara\u015ft\u0131rma ve \u0130\u015f Uzmanl\u0131\u011f\u0131 Aras\u0131nda K\u00f6pr\u00fc Kurmak<\/h3><p>Her b\u00fcy\u00fck inovasyonun arkas\u0131nda vizyonu hayata ge\u00e7irebilecek uzmanlardan olu\u015fan bir ekip vard\u0131r. Risk sermayedarlar\u0131, \u00f6zellikle risklerin y\u00fcksek ve ortam\u0131n karma\u015f\u0131k oldu\u011fu biyoteknoloji alan\u0131nda, bir giri\u015fimin liderlik ekibine \u00f6nemli bir a\u011f\u0131rl\u0131k verir.<\/p><p>2024'te trend ne olacak? Yat\u0131r\u0131mc\u0131lar, bilimsel uzmanl\u0131\u011f\u0131 operasyonel beceriyle harmanlayan ekiplere giderek daha fazla odaklan\u0131yor. Klinik deneyler, ruhsatland\u0131rma engelleri ve b\u00fcy\u00fck ila\u00e7 \u015firketleriyle ortakl\u0131klar konusunda deneyimli bir dan\u0131\u015fmanlar veya y\u00f6neticiler kuruluna sahip olmak \u00e7ok \u00f6nemli hale geliyor. Liderlikte derinli\u011fi olmayan d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc bir fikre sahip bir giri\u015fim, b\u00fcy\u00fcme ve i\u015fbirli\u011fi i\u00e7in g\u00fc\u00e7l\u00fc bir temel \u00fczerine in\u015fa edilmi\u015f bir giri\u015fimden \u00e7ok daha az caziptir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-03087df elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"03087df\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6868bad\" data-id=\"6868bad\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ea89963 elementor-widget elementor-widget-text-editor\" data-id=\"ea89963\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Yat\u0131r\u0131mc\u0131larla Stratejik Uyum: Ba\u015far\u0131ya Giden Yol<\/h3><p>Risk sermayesini g\u00fcvence alt\u0131na almak g\u00fcn\u00fcn sonunda stratejik uyuma ba\u011fl\u0131d\u0131r. Yat\u0131r\u0131mc\u0131lar, ister belirli bir terap\u00f6tik alan isterse sa\u011fl\u0131k hizmetlerinde s\u00fcrd\u00fcr\u00fclebilirlik taahh\u00fcd\u00fc olsun, vizyonu kendileriyle uyumlu olan \u015firketlerle ortakl\u0131k kurmak ister. Mevcut pazar taleplerini kar\u015f\u0131lad\u0131klar\u0131n\u0131 kan\u0131tlayabilen ve gelecekteki yenilikleri te\u015fvik etme potansiyeline sahip olan giri\u015fimlerin finansman sa\u011flama olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir.<\/p><p>Biyoteknoloji kurucular\u0131 i\u00e7in bu, hedef yat\u0131r\u0131mc\u0131lar\u0131n\u0131z\u0131 neyin harekete ge\u00e7irdi\u011fini anlamak i\u00e7in zaman ay\u0131rmak anlam\u0131na gelir. Hedeflerinizi onlar\u0131nkiyle uyumlu hale getirin ve \u015firketinizin bilimsel at\u0131l\u0131mlar ve finansal getiriler sa\u011flamak i\u00e7in nas\u0131l konumland\u0131\u011f\u0131n\u0131 g\u00f6sterin.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9ee3c66 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9ee3c66\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3835651\" data-id=\"3835651\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5c35eb7 elementor-widget elementor-widget-heading\" data-id=\"5c35eb7\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Biyoteknoloji Giri\u015fimleri i\u00e7in Kaynak Yaratma Zorluklar\u0131n\u0131n \u00dcstesinden Gelme <\/h2>\n<div><span><\/span><\/div><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-290b133 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"290b133\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7557476\" data-id=\"7557476\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ddc4f5b elementor-widget elementor-widget-text-editor\" data-id=\"ddc4f5b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknoloji giri\u015fimleri, sermaye bulma m\u00fccadelesine yabanc\u0131 de\u011fildir. Yat\u0131r\u0131mc\u0131lar\u0131n sekt\u00f6re olan ilgisi artarken, yeni kurulan \u015firketler genellikle \u00f6zel bilgi ve stratejik \u00f6ng\u00f6r\u00fc gerektiren farkl\u0131 engellerle kar\u015f\u0131la\u015f\u0131yor. En \u00f6nemli zorluk? Finansal destek sunan ve \u015firketin uzun vadeli vizyonunu payla\u015fan, ila\u00e7 geli\u015ftirme ya\u015fam d\u00f6ng\u00fcs\u00fcn\u00fcn karma\u015f\u0131kl\u0131\u011f\u0131n\u0131 anlayan yat\u0131r\u0131mc\u0131lar bulmak.<\/p><p>Geleneksel teknoloji giri\u015fimlerinin aksine, biyoteknoloji \u015firketleri uzun zaman \u00e7izelgelerinde \u00e7al\u0131\u015f\u0131r ve titiz yasal onaylar ve Ar-Ge ile ili\u015fkili y\u00fcksek riskleri y\u00f6netir. Bu fakt\u00f6rler benzersiz engeller yarat\u0131rken ayn\u0131 zamanda uzun vadeli potansiyeli g\u00f6ren yat\u0131r\u0131mc\u0131larla stratejik ortakl\u0131klar i\u00e7in f\u0131rsatlar da sunuyor.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-91de195 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"91de195\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-35ebf68\" data-id=\"35ebf68\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c343736 elementor-widget elementor-widget-text-editor\" data-id=\"c343736\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Karma\u015f\u0131k D\u00fczenleyici Engellerin A\u015f\u0131lmas\u0131<\/h3><p>Mevzuata uyum, \u00f6zellikle erken a\u015fama finansman aray\u0131\u015f\u0131nda olan biyoteknoloji giri\u015fimleri i\u00e7in temel bir zorluk olmaya devam etmektedir. FDA ve EMA gibi kurumlar yeni tedavilerin g\u00fcvenli\u011fini ve etkinli\u011fini sa\u011flamak i\u00e7in kat\u0131 kurallar uygulamaktad\u0131r, ancak bu kurallar ilerlemeyi yava\u015flatabilir ve uyum standartlar\u0131n\u0131 kar\u015f\u0131lamak i\u00e7in kapsaml\u0131 mali kaynaklar talep edebilir. Bu durum, ivmeyi korurken bu engelleri a\u015fabilecek uzmanl\u0131\u011fa ve esnekli\u011fe sahip olduklar\u0131n\u0131 yat\u0131r\u0131mc\u0131lara kan\u0131tlamak zorunda olan yeni giri\u015fimler i\u00e7in gerilim yaratmaktad\u0131r.<\/p><p>2023 y\u0131l\u0131 i\u00e7in bir rapor <a href=\"https:\/\/bio.widen.net\/s\/9ltmcfhbk9\/the-state-of-emerging-biotech-companies-investment-deal-and-pipeline-trends\" target=\"_blank\" rel=\"noopener\">Biyoteknoloji \u0130novasyon Organizasyonu (BIO)<\/a> biyoteknoloji kurucular\u0131n\u0131n yar\u0131s\u0131ndan fazlas\u0131n\u0131n mevzuat engellerini kaynak yaratma \u00e7abalar\u0131n\u0131n \u00f6n\u00fcndeki ba\u015fl\u0131ca engellerden biri olarak g\u00f6rd\u00fc\u011f\u00fcn\u00fc ortaya koymu\u015ftur. Yeni ba\u015flayanlar i\u00e7in, yat\u0131r\u0131mc\u0131lara sunumlar\u0131n\u0131n bir par\u00e7as\u0131 olarak mevzuata haz\u0131rl\u0131kl\u0131 olduklar\u0131n\u0131 vurgulamak, onay s\u00fcreci hakk\u0131ndaki bilgilerini ve bu gereklilikleri kar\u015f\u0131lama becerilerini g\u00f6stermek \u00e7ok \u00f6nemlidir. Bu engelin \u00fcstesinden gelebilecek donan\u0131ma sahip olduklar\u0131n\u0131 kan\u0131tlayabilen \u015firketlerin, \u00f6zellikle biyoteknoloji sekt\u00f6r\u00fcn\u00fcn inceliklerini bilen yat\u0131r\u0131mc\u0131lardan fon sa\u011flama olas\u0131l\u0131\u011f\u0131 daha y\u00fcksektir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7a99502 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7a99502\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-35577fc\" data-id=\"35577fc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-47df3a6 elementor-widget elementor-widget-text-editor\" data-id=\"47df3a6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Ekonomik Belirsizli\u011fin Ba\u011f\u0131\u015f Toplama \u00dczerindeki Etkisi<\/h3><p>Biyoteknoloji alan\u0131nda ba\u011f\u0131\u015f toplanmas\u0131 da ekonomik de\u011fi\u015fimlere kar\u015f\u0131 savunmas\u0131zd\u0131r. Finansal istikrars\u0131zl\u0131k d\u00f6nemlerinde, yat\u0131r\u0131mc\u0131lar daha d\u00fc\u015f\u00fck riskli sekt\u00f6rlere y\u00f6nelme e\u011filiminde olur ve bu da biyoteknoloji \u015firketlerini istikrars\u0131z bir konumda b\u0131rak\u0131r. Kaynak yaratma s\u00fcreleri genellikle uzar ve yeni kurulan \u015firketler daha zorlu m\u00fczakerelerle kar\u015f\u0131 kar\u015f\u0131ya kalabilir, bu da daha az elveri\u015fli ko\u015fullarla sonu\u00e7lanabilir. Bu durum, piyasa oynakl\u0131\u011f\u0131n\u0131n temkinli yat\u0131r\u0131mc\u0131 davran\u0131\u015f\u0131na yol a\u00e7t\u0131\u011f\u0131 ve fon ak\u0131\u015f\u0131n\u0131 kesintiye u\u011fratt\u0131\u011f\u0131 COVID-19 salg\u0131n\u0131 s\u0131ras\u0131nda \u00f6zellikle belirgindi.<\/p><p>Bilgili biyoteknoloji giri\u015fimleri, finansman kaynaklar\u0131n\u0131 \u00e7e\u015fitlendirerek, hibeler yoluyla suland\u0131r\u0131c\u0131 olmayan fonlardan yararlanarak ve kendilerini acil halk sa\u011fl\u0131\u011f\u0131 krizlerini \u00e7\u00f6zen yenilik\u00e7iler olarak konumland\u0131rarak bu zorlu\u011fu bir f\u0131rsata d\u00f6n\u00fc\u015ft\u00fcrebilir. Giri\u015fimler, ekonomik belirsizlik s\u0131ras\u0131nda dayan\u0131kl\u0131l\u0131k g\u00f6stererek, d\u0131\u015f zorluklara ra\u011fmen y\u00fcksek getiri vaat eden \u00e7\u0131\u011f\u0131r a\u00e7an teknolojiler arayan yat\u0131r\u0131mc\u0131lara hitap edebilir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-65a4601 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"65a4601\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e74e15c\" data-id=\"e74e15c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5b43cec elementor-widget elementor-widget-text-editor\" data-id=\"5b43cec\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Veri G\u00fcvenli\u011fi: Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Tart\u0131\u015f\u0131lmaz Bir Konu<\/h3>\n<p>Veri, biyoteknoloji inovasyonunun merkezinde yer al\u0131r, ancak yeni ba\u015flayanlar i\u00e7in en b\u00fcy\u00fck zorluklardan birini olu\u015fturur. \u00d6zellikle dijital i\u015fbirli\u011fi ve ara\u015ft\u0131rma platformlar\u0131 giri\u015fimleri siber sald\u0131r\u0131lara, veri ihlallerine ve fikri m\u00fclkiyet h\u0131rs\u0131zl\u0131\u011f\u0131na kar\u015f\u0131 daha savunmas\u0131z hale getirdi\u011finden, hassas ara\u015ft\u0131rma ve \u00f6zel bilgilerin korunmas\u0131 kritik \u00f6nem ta\u015f\u0131maktad\u0131r. Bu tehditler bir startup'\u0131n itibar\u0131na ve finansman sa\u011flama beklentilerine ciddi zarar verebilir.<\/p>\n<p>A <a href=\"https:\/\/www.pwc.com\/gx\/en\/issues\/cybersecurity\/global-digital-trust-insights.html\" target=\"_blank\" rel=\"noopener\">2024 PwC anketi<\/a> risk sermayedarlar\u0131n\u0131n \u00e7o\u011funun veri g\u00fcvenli\u011fini biyoteknoloji yat\u0131r\u0131mlar\u0131n\u0131n de\u011ferlendirilmesinde kritik bir unsur olarak g\u00f6rd\u00fc\u011f\u00fcn\u00fc ortaya koymu\u015ftur. Kapsaml\u0131 bir veri g\u00fcvenli\u011fi stratejisine sahip olmayan giri\u015fimler, yat\u0131r\u0131mc\u0131 g\u00fcvenini kaybetme riskiyle kar\u015f\u0131 kar\u015f\u0131ya kalarak fon toplama ve ilerleme kaydetme becerilerini potansiyel olarak engellemektedir.<\/p>\n<p>K\u00f6t\u00fc veri korumas\u0131n\u0131n sonu\u00e7lar\u0131 a\u011f\u0131rd\u0131r. 2022 y\u0131l\u0131nda, b\u00fcy\u00fck biyoteknoloji firmas\u0131 Enzo Biochem, klinik ara\u015ft\u0131rma verilerini tehlikeye atan bir ihlal ya\u015fad\u0131 ve bu da gecikmelere, hisse senedi de\u011ferinde d\u00fc\u015f\u00fc\u015fe ve kilit yat\u0131r\u0131mc\u0131lar\u0131n kayb\u0131na neden oldu.<sup>7<\/sup> Bu olay, yat\u0131r\u0131mc\u0131 g\u00fcvenini s\u00fcrd\u00fcrmek ve yenilikleri korumak i\u00e7in ilk g\u00fcnden itibaren veri g\u00fcvenli\u011fine \u00f6ncelik vermenin \u00f6nemini vurgulamaktad\u0131r.<\/p>\n<p>Biyoteknoloji giri\u015fimleri i\u00e7in, geli\u015fmi\u015f veri koruma \u00f6nlemlerini faaliyetlerine entegre etmek ve bu taahh\u00fcd\u00fc potansiyel yat\u0131r\u0131mc\u0131lara vurgulamak iste\u011fe ba\u011fl\u0131 de\u011fildir; kaynak yaratma ortam\u0131nda rekabet g\u00fcc\u00fcn\u00fc korumak i\u00e7in gereklidir.<\/p>\n<h3 style=\"font-family: Ubuntu, sans-serif; color: #303030;\">Ara\u015ft\u0131rma Verilerinin Korunmas\u0131 i\u00e7in En \u0130yi Uygulamalar<\/h3>\n<p>Biyoteknoloji giri\u015fimleri, a\u015fa\u011f\u0131dakiler de dahil olmak \u00fczere \u00e7e\u015fitli veri koruma stratejileri uygulamal\u0131d\u0131r:<\/p>\n<ul style=\"font-size: 18px; background-color: #ffffff;\">\n<li style=\"font-size: 18px;\"><b>Patent Stratejisi<br><\/b><ul style=\"font-size: 18px;\">\n<li style=\"font-size: 18px;\">Patentler fikri m\u00fclkiyeti korurken, zamanlama kritik \u00f6nem ta\u015f\u0131r. \u00c7ok erken ba\u015fvurmak hassas bilgileri a\u00e7\u0131\u011fa \u00e7\u0131karabilirken, \u00e7ok uzun s\u00fcre gecikmek rakiplerin devreye girmesi riskini do\u011furabilir. Korumay\u0131 en \u00fcst d\u00fczeye \u00e7\u0131karmak i\u00e7in dikkatli planlama \u015fartt\u0131r.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"font-size: 18px; background-color: #ffffff;\">\n<li style=\"font-size: 18px;\"><b>Ticari S\u0131rlar ve Sanal Veri Odalar\u0131 (VDR'ler)<br><\/b><ul style=\"font-size: 18px;\">\n<li style=\"font-size: 18px;\">Ticari s\u0131rlar, patenti al\u0131namayan tescilli s\u00fcre\u00e7lere bir alternatif sunar. Gizlilik anla\u015fmalar\u0131 ve g\u00fcvenli depolama yoluyla gizlili\u011fin korunmas\u0131 kilit \u00f6neme sahiptir. VDR'ler hassas belgelerin yat\u0131r\u0131mc\u0131larla g\u00fcvenli bir \u015fekilde payla\u015f\u0131lmas\u0131n\u0131 sa\u011flar, eri\u015fimi kontrol etmek i\u00e7in \u015fifreleme ve denetim izleri sunar.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"font-size: 18px; background-color: #ffffff;\">\n<li style=\"font-size: 18px;\"><b>\u015eifreleme ve G\u00fcvenlik Denetimleri<br><\/b><ul style=\"font-size: 18px;\">\n<li style=\"font-size: 18px;\">\u015eifreleme, \u00f6zellikle \u00e7ok fakt\u00f6rl\u00fc kimlik do\u011frulama (MFA) ile birlikte, verilerin g\u00fcvenli\u011fini sa\u011flamak i\u00e7in gereklidir. D\u00fczenli denetimler ve \u00e7al\u0131\u015fan e\u011fitimi, g\u00fcvenlik a\u00e7\u0131klar\u0131n\u0131n belirlenmesine yard\u0131mc\u0131 olur ve g\u00fcvenlik protokollerinin etkili kalmas\u0131n\u0131 sa\u011flar.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Bu uygulamalar\u0131 benimseyen biyoteknoloji giri\u015fimleri verilerini korur ve rekabet\u00e7i ba\u011f\u0131\u015f toplama ortam\u0131ndaki konumlar\u0131n\u0131 g\u00fc\u00e7lendirir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5189f70 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5189f70\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fa0e056\" data-id=\"fa0e056\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-648c930 elementor-widget elementor-widget-heading\" data-id=\"648c930\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Biyoteknoloji Ba\u011f\u0131\u015f Toplama S\u00fcrecinde Veri G\u00fcvenli\u011finin \u00d6nemli Rol\u00fc <\/h2>\n<span><\/span><div><span><\/span><\/div><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-17c81a9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"17c81a9\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7a10e8a\" data-id=\"7a10e8a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e7a1031 elementor-widget elementor-widget-text-editor\" data-id=\"e7a1031\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Veri, biyoteknolojide inovasyonun ve fikri m\u00fclkiyetin (IP) can damar\u0131d\u0131r. \u0130leri d\u00fczey ara\u015ft\u0131rmalar, klinik deneyler ve tescilli teknolojiler s\u00f6z konusu oldu\u011funda, veri g\u00fcvenli\u011fi bir arka ofis kayg\u0131s\u0131ndan biyoteknoloji alan\u0131nda kaynak yaratmada \u00f6nemli bir farkl\u0131la\u015ft\u0131r\u0131c\u0131ya d\u00f6n\u00fc\u015fm\u00fc\u015ft\u00fcr. Yeni ba\u015flayanlar i\u00e7in, hassas bilgilerin korunmas\u0131na y\u00f6nelik titiz bir taahh\u00fct g\u00f6stermek, yat\u0131r\u0131mc\u0131 g\u00f6r\u00fc\u015fmelerini yapabilir veya bozabilir.<\/p><p>Veri g\u00fcvenli\u011fi, giri\u015fiminizin bilimsel ve finansal y\u00f6nleri kadar kritik \u00f6neme sahiptir. Yat\u0131r\u0131mc\u0131lar, durum tespiti s\u0131ras\u0131nda hassas bilgiler i\u00e7in hava ge\u00e7irmez bir koruma bekler. \u0130\u015fte biyoteknoloji giri\u015fimlerinin verilerini nas\u0131l g\u00fcvence alt\u0131na alabilecekleri ve fikri m\u00fclkiyetlerini nas\u0131l koruyabilecekleri.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0e05d69 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0e05d69\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f90fb4c\" data-id=\"f90fb4c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a9bf6f0 elementor-widget elementor-widget-text-editor\" data-id=\"a9bf6f0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Veri G\u00fcvenli\u011fi i\u00e7in En \u0130yi Uygulamalar\u0131n Hayata Ge\u00e7irilmesi<\/h3><p>Geli\u015fmi\u015f veri koruma stratejileri uygulamak biyoteknoloji giri\u015fimleri i\u00e7in \u00e7ok \u00f6nemlidir. En iyi uygulamalar aras\u0131nda Sanal Veri Odalar\u0131 (VDR) kullanmak, g\u00fc\u00e7l\u00fc \u015fifreleme kullanmak ve s\u0131k s\u0131k g\u00fcvenlik denetimleri yapmak yer al\u0131r. Bu uygulamalar, hassas ara\u015ft\u0131rmalar\u0131n ve tescilli verilerin ba\u011f\u0131\u015f toplama s\u00fcreci boyunca ve sonras\u0131nda g\u00fcvende kalmas\u0131n\u0131 sa\u011flamaya yard\u0131mc\u0131 olur.<\/p><h3>Sanal Veri Odalar\u0131: Belgeleri G\u00fcvenle Payla\u015f\u0131n<\/h3><p>VDR'ler gizli belgelerin yat\u0131r\u0131mc\u0131lar ve ortaklarla payla\u015f\u0131lmas\u0131 i\u00e7in g\u00fcvenli ve kontroll\u00fc bir ortam sunar. \u015eifreleme, kullan\u0131c\u0131 kimlik do\u011frulamas\u0131 ve denetim izleri gibi \u00f6zellikleriyle VDR'ler giderek durum tespiti s\u00fcre\u00e7lerinin tart\u0131\u015f\u0131lmaz bir unsuru haline gelmektedir. Bir\u00e7ok risk sermayedar\u0131, de\u011ferlendirme a\u015famas\u0131nda VDR'leri \u00f6ncelikle \u015fifreleme yetenekleri ve yetkisiz if\u015fa riskini en aza indiren ayr\u0131nt\u0131l\u0131 eri\u015fim kontrol\u00fc nedeniyle tercih etmektedir.<\/p><p>Bu teknolojiyi uygulayan giri\u015fimler yat\u0131r\u0131mc\u0131lara veri g\u00fcvenli\u011fini ve operasyonel verimlili\u011fi ciddiye ald\u0131klar\u0131n\u0131n sinyalini verirler - g\u00fcven olu\u015fturmada iki kritik fakt\u00f6r. Kazara s\u0131z\u0131nt\u0131 olas\u0131l\u0131\u011f\u0131n\u0131 azaltmak i\u00e7in hassas bilgilere eri\u015fimin yaln\u0131zca ihtiyac\u0131 olanlarla s\u0131n\u0131rland\u0131r\u0131ld\u0131\u011f\u0131ndan emin olun. VDR'ler durum tespiti s\u00fcrecinizi temiz ve g\u00fcvenli tutman\u0131za yard\u0131mc\u0131 olur.<\/p><h3>\u015eifreleme: Her Ad\u0131mda Verileri Koruma<\/h3><p>\u015eifreleme, veri ihlallerinin inovasyon ve piyasa de\u011feri i\u00e7in felaket anlam\u0131na gelebilece\u011fi bir sekt\u00f6rde biyoteknoloji \u015firketleri i\u00e7in en etkili ara\u00e7lardan biri olmaya devam ediyor. Veriler ister beklemede ister aktar\u0131mda olsun, \u015fifreleme, ele ge\u00e7irilen verilere kolayca eri\u015filememesini veya bunlardan yararlan\u0131lamamas\u0131n\u0131 sa\u011flar.<\/p><p>Yat\u0131r\u0131mc\u0131lar\u0131n veri g\u00fcvenli\u011fi konusundaki incelemeleri artarken, \u015fifrelenmi\u015f i\u015f ak\u0131\u015flar\u0131na sahip giri\u015fimler \u00f6ne \u00e7\u0131kmak i\u00e7in daha iyi bir konumdad\u0131r. \u015eifrelemeyi \u00e7ok fakt\u00f6rl\u00fc kimlik do\u011frulama (MFA) ile birle\u015ftirmek, yaln\u0131zca yetkili personelin kritik belgelere eri\u015fmesini sa\u011flayarak ekstra bir koruma katman\u0131 ekler.<\/p><h3>S\u0131k G\u00fcvenlik Denetimleri ve G\u00fcncellemeleri: Tehditlerin \u00d6n\u00fcnde Olmak<\/h3><p>Siber tehditler s\u00fcrekli geli\u015fmektedir ve biyoteknoloji giri\u015fimleri siber g\u00fcvenlik protokollerini d\u00fczenli olarak g\u00fcncelleyerek ve s\u0131k s\u0131k g\u00fcvenlik denetimleri yaparak bu risklerin \u00f6n\u00fcne ge\u00e7melidir. Bu denetimler, sistemdeki zay\u0131f noktalar\u0131n istismar edilmeden \u00f6nce tespit edilmesine yard\u0131mc\u0131 olarak verilerin giri\u015fimin b\u00fcy\u00fcmesi boyunca g\u00fcvende kalmas\u0131n\u0131 sa\u011flar.<\/p><p>\u00c7al\u0131\u015fanlar\u0131n en iyi veri g\u00fcvenli\u011fi uygulamalar\u0131 konusunda iyi e\u011fitilmi\u015f olmalar\u0131n\u0131 sa\u011flamak da ayn\u0131 derecede \u00f6nemlidir. \u0130nsan hatas\u0131, veri ihlallerinin ana nedenlerinden biri olmaya devam etmektedir; bu da personelin e\u011fitimini ve fark\u0131ndal\u0131\u011f\u0131n\u0131 \u00e7ok \u00f6nemli bir savunma hatt\u0131 haline getirmektedir. Geli\u015fmi\u015f teknoloji \u00e7\u00f6z\u00fcmlerini iyi e\u011fitimli bir i\u015fg\u00fcc\u00fcyle birle\u015ftiren biyoteknoloji giri\u015fimleri kendilerini g\u00fcvenilir, ileri g\u00f6r\u00fc\u015fl\u00fc \u015firketler olarak konumland\u0131r\u0131r; bu da g\u00fcn\u00fcm\u00fczde yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir niteliktir.<\/p><h3>Vaka \u00c7al\u0131\u015fmalar\u0131: Uygulamada Veri G\u00fcvenli\u011fi<\/h3><p>G\u00fc\u00e7l\u00fc veri g\u00fcvenli\u011fi \u00f6nlemlerinin, yat\u0131r\u0131m \u00e7ekmek isteyen biyoteknoloji giri\u015fimleri i\u00e7in \u00f6nemli bir farkl\u0131la\u015ft\u0131r\u0131c\u0131 unsur oldu\u011fu kan\u0131tlanm\u0131\u015ft\u0131r. Moderna gibi giri\u015fimler, veri korumaya \u00f6ncelik vermenin nas\u0131l \u00f6nemli bir kaynak yaratma ba\u015far\u0131s\u0131 sa\u011flayabilece\u011fini g\u00f6stermi\u015ftir. Moderna, geli\u015fmi\u015f mRNA teknolojisini geli\u015ftirmenin ilk a\u015famalar\u0131nda \u015fifrelenmi\u015f VDR'ler uygulad\u0131 ve \u00e7abay\u0131 korumak i\u00e7in d\u00fczenli g\u00fcvenlik denetimleri ger\u00e7ekle\u015ftirdi. G\u00fcvenli\u011fe olan bu ba\u011fl\u0131l\u0131k, y\u00fcksek profilli yat\u0131r\u0131mc\u0131larla g\u00fcven olu\u015fturmada hayati bir rol oynad\u0131 ve $4 milyardan fazla fon elde edilmesini sa\u011flad\u0131.<sup>8<\/sup><\/p><p>Ba\u015fka bir \u00f6rnek de <a href=\"https:\/\/digify.com\/case-studies\/stratificare-uses-digify-to-streamline-investor-engagement-during-fundraising\/\" target=\"_blank\" rel=\"noopener\">Stratificare<\/a>, Dang hummas\u0131 i\u00e7in tan\u0131 testleri olu\u015fturmaya odaklanan bir biyoteknoloji giri\u015fimi. Digify'\u0131n g\u00fcvenli VDR'lerini kullanarak \u015firket, kaynak yaratma \u00e7abalar\u0131n\u0131 kolayla\u015ft\u0131rabildi ve veri korumaya olan ba\u011fl\u0131l\u0131\u011f\u0131n\u0131 g\u00f6sterebildi. Yat\u0131r\u0131mc\u0131lar, durum tespiti s\u0131ras\u0131nda payla\u015f\u0131lan hassas ara\u015ft\u0131rma verilerinin g\u00fcvende oldu\u011fundan emin oldular, bu da \u015firketin anla\u015fmalar\u0131 daha h\u0131zl\u0131 kapatmas\u0131na ve fikri m\u00fclkiyetini korumas\u0131na yard\u0131mc\u0131 oldu.<\/p><p><a href=\"https:\/\/digify.com\/case-studies\/medtech-startup-omeza-uses-digify-for-fundraising-and-sharing-sensitive-information\/\" target=\"_blank\" rel=\"noopener\">Omeza<\/a>, Kronik yara bak\u0131m\u0131 i\u00e7in tedaviler geli\u015ftiren bir startup olan Omeza, hassas belgelerini g\u00fcvenli bir \u015fekilde y\u00f6netmek i\u00e7in Digify'\u0131n VDR'lerini kulland\u0131. Platform, Omeza'n\u0131n belge eri\u015fimini izlemesine ve izinleri ayarlamas\u0131na olanak tan\u0131yarak verileri \u00fczerinde tam kontrol sahibi olmalar\u0131n\u0131 sa\u011flad\u0131 ve potansiyel yat\u0131r\u0131mc\u0131lara g\u00fcven a\u015f\u0131lad\u0131.<\/p><p>Veri g\u00fcvenli\u011fine \u00f6ncelik vermemenin sonu\u00e7lar\u0131 y\u0131k\u0131c\u0131 olabilir. <a href=\"https:\/\/www.bigmoleculewatch.com\/2019\/09\/06\/settlement-reached-in-genentech-v-jhl-biosimilar-trade-secrets-case\/\" target=\"_blank\" rel=\"noopener\">JHL Biotech<\/a>, \u00d6rne\u011fin, \u015firketin eski bir ba\u015f bilim adam\u0131n\u0131n yard\u0131m\u0131yla Genentech'ten tescilli kanser ilac\u0131 verilerini \u00e7ald\u0131\u011f\u0131 ortaya \u00e7\u0131kt\u0131\u011f\u0131nda bir skandala kar\u0131\u015ft\u0131. Bu fikri m\u00fclkiyet h\u0131rs\u0131zl\u0131\u011f\u0131, b\u00fcy\u00fck bir davaya ve \u015firketin itibar\u0131nda onar\u0131lamaz bir hasara yol a\u00e7t\u0131.<\/p><p>Ayn\u0131 \u015fekilde, <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/roche-sues-stanford-university-cancer-detection-startup-over-trade-secrets-2024-07-02\/\" target=\"_blank\" rel=\"noopener\">Roche<\/a> yanl\u0131\u015fl\u0131kla bir akci\u011fer kanseri ila\u00e7 denemesinin ara verilerini a\u00e7\u0131klam\u0131\u015f, bu da kesin olmayan bulgular\u0131n erken a\u00e7\u0131klanmas\u0131 nedeniyle yat\u0131r\u0131mc\u0131 g\u00fcvenini etkilemi\u015ftir. Ba\u015fka bir vakada, <a href=\"https:\/\/therecord.media\/clinical-test-data-of-enzio-biochem-stolen\" target=\"_blank\" rel=\"noopener\">Enzo Biyokimya<\/a> 'nin 2,5 milyon hastan\u0131n hassas klinik test verilerini a\u00e7\u0131\u011fa \u00e7\u0131karan bir fidye yaz\u0131l\u0131m\u0131 sald\u0131r\u0131s\u0131yla kar\u015f\u0131 kar\u015f\u0131ya kalmas\u0131, verilerin ele ge\u00e7irilmesi durumunda ortaya \u00e7\u0131kabilecek y\u0131k\u0131c\u0131 mali ve itibar hasar\u0131n\u0131n alt\u0131n\u0131 \u00e7izdi.<\/p><p>Bu \u00f6rnekler, s\u0131z\u0131nt\u0131lar yat\u0131r\u0131mc\u0131 g\u00fcvenini etkileyebilece\u011finden ve \u00f6nemli mali kay\u0131plara yol a\u00e7abilece\u011finden, biyoteknoloji \u015firketlerinin en ba\u015f\u0131ndan itibaren s\u0131k\u0131 veri g\u00fcvenli\u011fi \u00f6nlemleri almalar\u0131 gerekti\u011fini vurgulamaktad\u0131r.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6c41818 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6c41818\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c320881\" data-id=\"c320881\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ee7b8e1 elementor-widget elementor-widget-heading\" data-id=\"ee7b8e1\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Durum Tespiti Kontrol Listesi: Biyoteknoloji Giri\u015fimleri Yat\u0131r\u0131mc\u0131 Finansman\u0131n\u0131 Nas\u0131l G\u00fcvence Alt\u0131na Alabilir? <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-bd07ed4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"bd07ed4\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3b2bfba\" data-id=\"3b2bfba\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-24ce818 elementor-widget elementor-widget-text-editor\" data-id=\"24ce818\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Durum tespiti i\u00e7in haz\u0131rl\u0131k yapmak, yat\u0131r\u0131m \u00e7ekmenin ve g\u00fcvence alt\u0131na alman\u0131n tart\u0131\u015f\u0131lmaz bir par\u00e7as\u0131d\u0131r. Yat\u0131r\u0131mc\u0131lar biliminizin d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc oldu\u011funu ve operasyonlar\u0131n\u0131z\u0131n sa\u011flam oldu\u011funu bilmek ister. Do\u011fru haz\u0131rl\u0131k, giri\u015fiminizi rakiplerinden ay\u0131rabilir ve kaynak yaratma ba\u015far\u0131s\u0131 i\u00e7in gereken yat\u0131r\u0131mc\u0131 g\u00fcvenini olu\u015fturabilir.<\/p><p>Bu kontrol listesi, veri g\u00fcvenli\u011fi, mevzuata uygunluk ve di\u011fer temel bile\u015fenlere odaklan\u0131rken, biyoteknoloji giri\u015fiminizin durum tespiti i\u00e7in tamamen haz\u0131r olmas\u0131n\u0131 sa\u011flayarak temel hususlarda size rehberlik edecektir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8235e86 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8235e86\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-bd9fd6e\" data-id=\"bd9fd6e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fa1b185 elementor-widget elementor-widget-text-editor\" data-id=\"fa1b185\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>Durum Tespitinde Uzmanla\u015fmak i\u00e7in \u00d6nemli Ad\u0131mlar<\/h3><div><p><strong>\u2713 Finansal Belgeler: \u00d6l\u00e7eklendirmeye Uygun Oldu\u011funuzu G\u00f6sterin<br \/><\/strong>Yat\u0131r\u0131mc\u0131lar, k\u00e2r-zarar tablolar\u0131, bilan\u00e7olar ve nakit ak\u0131\u015f\u0131 raporlar\u0131 dahil olmak \u00fczere mali belgelerinizi inceleyecektir. Projeksiyonlar\u0131n\u0131z, giri\u015fiminizin nas\u0131l b\u00fcy\u00fcmeyi ve getiri elde etmeyi planlad\u0131\u011f\u0131n\u0131 ikna edici bir \u015fekilde g\u00f6stermelidir.\u00a0<\/p><p><strong>\u2713 Teknolojinizin De\u011ferini Kan\u0131tlay\u0131n<br \/><\/strong>\u00c7\u00f6z\u00fcm\u00fcn\u00fcz\u00fcn arkas\u0131ndaki ara\u015ft\u0131rma, klinik deneyler ve bilimsel veriler de dahil olmak \u00fczere incelenecektir. Ara\u015ft\u0131rman\u0131z kur\u015fun ge\u00e7irmez olmal\u0131d\u0131r; yat\u0131r\u0131mc\u0131lara, \u00e7\u00f6z\u00fcm\u00fcn\u00fcz\u00fcn pazarda uygulanabilirli\u011fini g\u00f6stermeye yard\u0131mc\u0131 olan etkinlik ve g\u00fcvenlik iddialar\u0131n\u0131 destekleyebilece\u011finizi g\u00f6stermelisiniz.<\/p><p><strong>\u2713 Fikri M\u00fclkiyet: Bulu\u015flar\u0131n\u0131z\u0131 Koruyun<br \/><\/strong>Kapsaml\u0131 bir fikri m\u00fclkiyet stratejisi kritik \u00f6nem ta\u015f\u0131r. Giri\u015fiminizin \u00e7\u00f6z\u00fcmleri, patent ba\u015fvurular\u0131ndan tescilli teknolojilere kadar korunmal\u0131d\u0131r. Sa\u011flam fikri m\u00fclkiyet korumas\u0131, rakiplerin fikirlerinizi kopyalamas\u0131n\u0131 \u00f6nler ve yat\u0131r\u0131mc\u0131lara i\u015fletmenizin ihlal risklerine kar\u015f\u0131 g\u00fcvende oldu\u011fu konusunda g\u00fcvence verir<\/p><p><strong>\u2713 Mevzuata Uyumluluk: K\u0131rm\u0131z\u0131 Band\u0131 A\u015fabilece\u011finizi Kan\u0131tlay\u0131n<br \/><\/strong>Y\u00fcksek d\u00fczeyde d\u00fczenlemeye tabi biyoteknoloji alan\u0131 g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, yat\u0131r\u0131mc\u0131lar\u0131n giri\u015fiminizin FDA veya EMA gibi d\u00fczenleyici kurumlarla ne kadar uyumlu oldu\u011funu anlamas\u0131 gerekir. Do\u011fru belgelere sahip oldu\u011funuzdan ve \u00fcr\u00fcn\u00fcn\u00fcz\u00fcn gerekli klinik deneyler ve onay s\u00fcre\u00e7lerinde ilerledi\u011fini kan\u0131tlayabildi\u011finizden emin olun.<\/p><div>\u00a0<\/div><div><h3>Durum Tespiti Haz\u0131rl\u0131\u011f\u0131n\u0131z\u0131 G\u00fc\u00e7lendirecek Kaynaklar<\/h3><div>\u0130\u015fte biyoteknoloji giri\u015fiminizin yat\u0131r\u0131mc\u0131 incelemesine haz\u0131r olmas\u0131n\u0131 sa\u011flamak i\u00e7in baz\u0131 temel kaynaklar:<\/div><div>\u00a0<\/div><div><b>Sanal Veri Odalar\u0131 (VDR'ler):<\/b> Digify gibi platformlar \u015fifreleme, belge takibi ve filigranlama sunarak <a href=\"https:\/\/digify.com\/vdr.html\/\" target=\"_blank\" rel=\"noopener\">belgelerinizi g\u00fcvende tutun<\/a> durum tespiti s\u0131ras\u0131nda.<\/div><div>\u00a0<\/div><div><b>Uyumluluk Ara\u00e7lar\u0131:<\/b> Digify'\u0131n uyumluluk y\u00f6netimi \u00e7\u00f6z\u00fcmleriyle d\u00fczenleyici belgeleri merkezile\u015ftirin ve d\u00fczenleyin; FDA, EMA ve di\u011fer d\u00fczenlemelerin y\u00f6netimini basitle\u015ftirin.<\/div><div>\u00a0<\/div><div><b>\u00dccretsiz Yat\u0131r\u0131m Durum Tespiti Kontrol Listesi:<\/b> Digify'\u0131 indirin <a href=\"https:\/\/digify.com\/free-investment-due-diligence-checklist-thank-you.html\" target=\"_blank\" rel=\"noopener\">\u00fccretsi\u0307z yatirim durum tespi\u0307ti\u0307 kontrol li\u0307stesi\u0307<\/a> Yat\u0131r\u0131mc\u0131 de\u011ferlendirmelerine tam olarak haz\u0131r oldu\u011funuzdan emin olmak i\u00e7in. Bu kaynak, ba\u015far\u0131l\u0131 bir ba\u011f\u0131\u015f toplama s\u00fcreci i\u00e7in neler beklemeniz ve verilerinizi nas\u0131l d\u00fczenlemeniz gerekti\u011fine dair ayr\u0131nt\u0131l\u0131 bir yol haritas\u0131 sunmaktad\u0131r.<\/div><div>\u00a0<\/div><div><b>Siber G\u00fcvenlik Uzmanlar\u0131:<\/b> Geli\u015fen tehditlere kar\u015f\u0131 savunmak i\u00e7in denetimler ve ekstra veri koruma katmanlar\u0131 i\u00e7in siber g\u00fcvenlik firmalar\u0131yla ortakl\u0131k kurmay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/div><div>Giri\u015fimler bu alanlara odaklanarak yat\u0131r\u0131mc\u0131lar\u0131n g\u00fcvenini kazanabilir ve gerekli finansman\u0131 sa\u011flama \u015fanslar\u0131n\u0131 art\u0131rabilirler.<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-84b81f8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"84b81f8\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9f9518c\" data-id=\"9f9518c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-278afb8 elementor-widget elementor-widget-heading\" data-id=\"278afb8\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> B\u00f6lgesel Da\u011f\u0131l\u0131m: Kuzey Amerika, Avrupa ve APAC <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a3f7be4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a3f7be4\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-073ca40\" data-id=\"073ca40\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a61a065 elementor-widget elementor-widget-text-editor\" data-id=\"a61a065\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>K\u00fcresel biyoteknoloji finansman ortam\u0131, yat\u0131r\u0131m e\u011filimlerini \u015fekillendiren farkl\u0131 b\u00f6lgesel \u00f6zelliklerle belirginle\u015ferek h\u0131zla geli\u015fmektedir. Her b\u00f6lge, biyoteknoloji giri\u015fimlerinin b\u00fcy\u00fcmek i\u00e7in ihtiya\u00e7 duyduklar\u0131 finansman\u0131 nas\u0131l sa\u011flad\u0131klar\u0131n\u0131 etkileyen benzersiz f\u0131rsatlar ve zorluklar sunmaktad\u0131r.<\/p><h3>Kuzey Amerika: Biyoteknoloji Yat\u0131r\u0131mlar\u0131n\u0131n G\u00fc\u00e7 Merkezi<\/h3><p>Kuzey Amerika, biyoteknoloji yat\u0131r\u0131mlar\u0131 i\u00e7in birincil b\u00f6lge olarak \u00f6ne \u00e7\u0131kmakta ve ABD \u00f6n planda yer almaktad\u0131r. Silikon Vadisi ve Boston \u00f6nde gelen merkezlerdir. 2023 y\u0131l\u0131nda biyoteknolojiye yap\u0131lan risk sermayesi yat\u0131r\u0131mlar\u0131, gen d\u00fczenleme ve hassas t\u0131p alan\u0131ndaki ilerlemelerin de etkisiyle $29,9 milyar gibi e\u015fi benzeri g\u00f6r\u00fclmemi\u015f bir rakama ula\u015fm\u0131\u015ft\u0131r.<sup>9<\/sup> Etkileyici bir \u015fekilde, bu yat\u0131r\u0131mlar\u0131n neredeyse yar\u0131s\u0131 gen d\u00fczenleme teknolojilerine ve biyolojik ila\u00e7lara odaklanan \u015firketleri hedef ald\u0131 ve inovasyona y\u00f6nelik g\u00fc\u00e7l\u00fc bir yat\u0131r\u0131mc\u0131 i\u015ftah\u0131n\u0131n alt\u0131n\u0131 \u00e7izdi.<\/p><p>Bununla birlikte, Kuzey Amerika'daki rekabet ortam\u0131 yo\u011funla\u015fm\u0131\u015ft\u0131r. Yat\u0131r\u0131mc\u0131lar giderek daha titiz davran\u0131yor ve durum tespitine her zamankinden daha fazla \u00f6ncelik veriyor. PitchBook taraf\u0131ndan 2024 y\u0131l\u0131nda yap\u0131lan bir anket, risk sermayedarlar\u0131n\u0131n \u00e7o\u011funun biyoteknoloji giri\u015fimlerini de\u011ferlendirirken veri g\u00fcvenli\u011fini kritik olarak g\u00f6rd\u00fc\u011f\u00fcn\u00fc ortaya koydu.<sup>10<\/sup><\/p><p>Bu artan odaklanma, g\u00fc\u00e7l\u00fc veri y\u00f6netimi uygulamalar\u0131n\u0131n hayata ge\u00e7irilmesinin elzem oldu\u011fu anlam\u0131na geliyor. Sanal Veri Odalar\u0131, hassas ara\u015ft\u0131rma verilerini payla\u015fmak ve potansiyel yat\u0131r\u0131mc\u0131larla etkili ileti\u015fimi kolayla\u015ft\u0131rmak i\u00e7in g\u00fcvenli bir platform sa\u011flayan standart bir ara\u00e7 haline gelmi\u015ftir.<\/p><h3>Avrupa: Kendi Zorluklar\u0131yla Y\u00fckselen Bir Y\u0131ld\u0131z<\/h3><p>Avrupa'n\u0131n biyoteknoloji sekt\u00f6r\u00fc, 2023 y\u0131l\u0131nda 11,46 milyar Avro'yu a\u015facak finansmanla dikkate de\u011fer bir y\u00fckseli\u015f e\u011filimindedir.<sup>11<\/sup> Birle\u015fik Krall\u0131k, Almanya ve \u0130svi\u00e7re, g\u00fc\u00e7l\u00fc devlet deste\u011fi ve biyoteknoloji firmalar\u0131 ile akademik kurumlar aras\u0131ndaki i\u015fbirli\u011fi \u00e7abalar\u0131 sayesinde \u00f6nemli biyoteknoloji merkezleri olarak ortaya \u00e7\u0131kmaktad\u0131r. Avrupa Komisyonu'nun Horizon Europe program\u0131, \u00f6n\u00fcm\u00fczdeki yedi y\u0131l i\u00e7inde 95,5 milyar Avroluk finansman taahh\u00fcd\u00fcyle k\u0131ta genelinde biyoteknoloji geli\u015fimini daha da art\u0131rmay\u0131 vaat ediyor.<sup>12<\/sup><\/p><p><a href=\"https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/can-european-biotechs-achieve-greater-scale-in-a-fragmented-landscape\" target=\"_blank\" rel=\"noopener\">Avrupal\u0131 biyoteknoloji giri\u015fimleri<\/a> \u00f6zellikle mevzuata uyum konusunda farkl\u0131 zorluklarla kar\u015f\u0131la\u015fmaktad\u0131r. Genel Veri Koruma Y\u00f6netmeli\u011fi (GDPR) s\u0131k\u0131 veri koruma gereklilikleri getirmekte ve titiz veri g\u00fcvenli\u011fi \u00f6nlemlerini zorunlu k\u0131lmaktad\u0131r. Uyumsuzluk \u00f6nemli para cezalar\u0131na yol a\u00e7abilir ve yat\u0131r\u0131mc\u0131 g\u00fcvenini a\u015f\u0131nd\u0131rabilir. Kapsaml\u0131 veri g\u00fcvenli\u011fi uygulamalar\u0131 olu\u015fturmak, se\u00e7ici Avrupal\u0131 yat\u0131r\u0131mc\u0131lardan yat\u0131r\u0131m \u00e7ekmek i\u00e7in \u00e7ok \u00f6nemlidir.<\/p><h3>APAC: Farkl\u0131 Dinamiklerle Y\u00fckselen S\u0131n\u0131r<\/h3><p>Asya-Pasifik (APAC) b\u00f6lgesi, 2023 y\u0131l\u0131nda $12 milyar\u0131n \u00fczerine \u00e7\u0131kacak yat\u0131r\u0131mlarla biyoteknoloji alan\u0131nda h\u0131zla g\u00fc\u00e7l\u00fc bir oyuncu olarak ortaya \u00e7\u0131kmaktad\u0131r.<sup>13<\/sup> \u00c7in ve Hindistan gibi \u00fclkeler, g\u00fc\u00e7l\u00fc h\u00fck\u00fcmet deste\u011fi ve biyoteknolojiye yap\u0131lan stratejik yat\u0131r\u0131mlarla desteklenen bu b\u00fcy\u00fcmeye \u00f6nc\u00fcl\u00fck ediyor. \u00c7in'in \u00c7in Ulusal Biyoteknoloji Grubu arac\u0131l\u0131\u011f\u0131yla mRNA teknolojisine olan ba\u011fl\u0131l\u0131\u011f\u0131, b\u00f6lgenin biyoteknoloji inovasyonuna olan ba\u011fl\u0131l\u0131\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7iziyor.<\/p><p>Singapur da son yirmi y\u0131ld\u0131r biyoteknoloji alan\u0131nda ba\u015far\u0131ya ula\u015fmak i\u00e7in \u00e7abalayan APAC biyoteknoloji ortam\u0131nda \u00f6nemli bir rol oynamaktad\u0131r. \u00dclke ara\u015ft\u0131rma ve geli\u015ftirmeye yat\u0131r\u0131m yapt\u0131k\u00e7a, biyoteknoloji inovasyonu i\u00e7in \u00f6nemli bir merkez olarak konumlan\u0131yor ve b\u00f6lgeyi daha da zenginle\u015ftiriyor.<\/p><p>B\u00fcy\u00fcmeye ra\u011fmen APAC biyoteknoloji pazar\u0131, farkl\u0131 pazar dinamikleri ve \u00fclkeler aras\u0131nda de\u011fi\u015fen yat\u0131r\u0131mc\u0131 beklentileri ile par\u00e7al\u0131 bir yap\u0131ya sahiptir. Bu zorluklar\u0131n \u00fcstesinden gelmek i\u00e7in APAC b\u00f6lgesindeki biyoteknoloji giri\u015fimleri, fikri m\u00fclkiyetlerini korumak ve yat\u0131r\u0131mc\u0131 g\u00fcvenini art\u0131rmak i\u00e7in VDR'ler de dahil olmak \u00fczere g\u00fcvenli veri y\u00f6netimi uygulamalar\u0131n\u0131 benimsemelidir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-930c97b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"930c97b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e53b1ce\" data-id=\"e53b1ce\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-cc6317a elementor-widget elementor-widget-heading\" data-id=\"cc6317a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Temel \u00c7\u0131kar\u0131mlar ve Stratejik \u00d6neriler <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ecd4cea elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ecd4cea\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-45af4bb\" data-id=\"45af4bb\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bbf2e9c elementor-widget elementor-widget-text-editor\" data-id=\"bbf2e9c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Biyoteknoloji giri\u015fimleri, ileri g\u00f6r\u00fc\u015fl\u00fc teknolojiler ile pratik uygulama aras\u0131nda denge kurmal\u0131d\u0131r. Geli\u015fmi\u015f tedaviler ve yakla\u015f\u0131mlar yat\u0131r\u0131mc\u0131lar\u0131n ilgisini \u00e7ekmek i\u00e7in gerekli olsa da, bunlar\u0131n ula\u015f\u0131labilir kilometre ta\u015flar\u0131 ve pazara giden ger\u00e7ek\u00e7i bir yolla desteklenmesi gerekir.<\/p><h3>Yenilik\u00e7ili\u011fi Pratiklikle Dengelemek<\/h3><p>Yat\u0131r\u0131mc\u0131lar ileri g\u00f6r\u00fc\u015fl\u00fc fikirlerden daha fazlas\u0131n\u0131 g\u00f6rmek isterler; net, uygulanabilir bir plana ihtiya\u00e7lar\u0131 vard\u0131r. Riskleri y\u00f6netirken inovasyonlar\u0131n\u0131z\u0131 nas\u0131l ilerletece\u011finizi g\u00f6steren ayr\u0131nt\u0131l\u0131 ad\u0131mlar sunun. Vizyoner kavramlar ve pratik uygulama aras\u0131ndaki bu denge, yat\u0131r\u0131mc\u0131lara sonu\u00e7 verme yetene\u011finiz konusunda g\u00fcven verir.<\/p><h3>Stratejik Ortakl\u0131klardan Yararlanma<\/h3><p>\u0130la\u00e7 \u015firketleri, akademik kurumlar veya di\u011fer biyoteknoloji firmalar\u0131 ile stratejik ortakl\u0131klar g\u00fcvenilirli\u011finizi art\u0131rabilir ve \u00f6nemli kaynaklar sa\u011flayabilir. Deloitte'a g\u00f6re, \u00f6nemli miktarda finansman sa\u011flayan biyoteknoloji giri\u015fimlerinin yar\u0131s\u0131ndan fazlas\u0131 ilk iki y\u0131llar\u0131nda en az bir stratejik ortakl\u0131k kurmu\u015ftur.<sup>14<\/sup> D\u0131\u015f destekten yararlanma kabiliyetinizi g\u00f6stermek i\u00e7in bu i\u015fbirliklerini vurgulay\u0131n.<\/p><h3>Yat\u0131r\u0131mc\u0131 Beklentilerine Uyum Sa\u011flama<\/h3><p>Yat\u0131r\u0131mc\u0131lar art\u0131k veri odakl\u0131 i\u00e7g\u00f6r\u00fcleri ve etik hususlar\u0131 vurguluyor. \u00d6ne \u00e7\u0131kmak i\u00e7in klinik deney sonu\u00e7lar\u0131 ve finansal projeksiyonlar gibi net, \u00f6l\u00e7\u00fclebilir veriler sunun. Hedeflerinizi toplumsal faydalarla uyumlu hale getirmek, de\u011fi\u015fen yat\u0131r\u0131mc\u0131 beklentilerini kar\u015f\u0131laman\u0131za yard\u0131mc\u0131 olur ve cazibenizi art\u0131r\u0131r.<\/p><h3>Uzun Vadeli S\u00fcrd\u00fcr\u00fclebilirlik i\u00e7in Haz\u0131rl\u0131k<\/h3><p>\u00d6l\u00e7eklenebilir bir i\u015f modeli olu\u015fturmaya ve g\u00fc\u00e7l\u00fc bir \u00fcr\u00fcn hatt\u0131n\u0131 s\u00fcrd\u00fcrmeye odaklan\u0131n. Yetenek ve altyap\u0131ya yat\u0131r\u0131m yapmak uzun vadeli b\u00fcy\u00fcme i\u00e7in kritik \u00f6neme sahiptir. S\u00fcrekli yenilik ve geni\u015fleme i\u00e7in sa\u011flam bir plan, acil ve kal\u0131c\u0131 de\u011fer arayan yat\u0131r\u0131mc\u0131lar\u0131 \u00e7ekecektir.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f4e6fb7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f4e6fb7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-841287f\" data-id=\"841287f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8297a95 elementor-widget elementor-widget-heading\" data-id=\"8297a95\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\"><h2> Biyoteknoloji Ba\u011f\u0131\u015f Toplama Stratejinizi Geli\u015ftirin: Veri G\u00fcvenli\u011finin G\u00fcc\u00fc <\/h2>\n<span><\/span><\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b8b3633 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b8b3633\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-79f84ec\" data-id=\"79f84ec\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5105488 elementor-widget elementor-widget-text-editor\" data-id=\"5105488\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Finansman i\u00e7in rekabet \u015fiddetlendik\u00e7e, biyoteknoloji yat\u0131r\u0131mc\u0131lar\u0131 fikri m\u00fclkiyet ve hassas ara\u015ft\u0131rma verilerini korumaya giderek daha fazla odaklan\u0131yor. Veri g\u00fcvenli\u011fi konusunda liderlik eden giri\u015fimler \u00f6nemli bir avantaj elde edebilir.<\/p><p>Biyoteknoloji liderleri i\u00e7in sa\u011flam veri korumas\u0131 en iyi uygulamadan \u00f6te stratejik bir zorunluluktur. \u015eirketler, g\u00fc\u00e7l\u00fc veri g\u00fcvenli\u011fi \u00f6nlemleri alarak yat\u0131r\u0131mc\u0131 g\u00fcveni olu\u015fturuyor, durum tespitini kolayla\u015ft\u0131r\u0131yor ve temel finansman\u0131 g\u00fcvence alt\u0131na al\u0131yor. Sanal Veri Odalar\u0131 i\u00e7in Digify gibi ara\u00e7lar verileri korur ve etkili biyoteknoloji ba\u011f\u0131\u015f toplamay\u0131 kolayla\u015ft\u0131r\u0131r.<\/p><p>Biyoteknoloji sekt\u00f6r\u00fc ilerlemeye devam ettik\u00e7e, veri g\u00fcvenli\u011fi uzun vadeli ba\u015far\u0131 elde etmek i\u00e7in hayati \u00f6nem ta\u015f\u0131yacakt\u0131r. Biyoteknoloji liderleri, verilerini korumak i\u00e7in kararl\u0131 ad\u0131mlar atmal\u0131 ve kurulu\u015flar\u0131n\u0131n s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcme, inovasyon ve giderek karma\u015f\u0131kla\u015fan bir pazarda rekabet avantaj\u0131 elde etmek i\u00e7in iyi bir konumda olmas\u0131n\u0131 sa\u011flamal\u0131d\u0131r.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e955362 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e955362\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-4ca0bb5\" data-id=\"4ca0bb5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-29f0cb0 elementor-blockquote--skin-boxed elementor-widget elementor-widget-blockquote\" data-id=\"29f0cb0\" data-element_type=\"widget\" data-widget_type=\"blockquote.default\">\n\t\t\t\t\t\t\t<blockquote class=\"elementor-blockquote\">\n\t\t\t<p class=\"elementor-blockquote__content\">\n\t\t\t\tDigify, belgeleriniz \u00fczerinde tam kontrol, koruma ve izleme sa\u011flayan bulut tabanl\u0131 belge g\u00fcvenli\u011fi ve veri odas\u0131 yaz\u0131l\u0131m\u0131d\u0131r. Belge eri\u015fim kontrol\u00fc, g\u00fc\u00e7l\u00fc \u015fifreleme, dosya takibi, yazd\u0131rma ve indirme izinleri ve \u00f6zelle\u015ftirilebilir filigran ekleme yetene\u011fi dahil olmak \u00fczere hepsi bir arada entegre bir \u00e7\u00f6z\u00fcm. 600.000'den fazla profesyonel taraf\u0131ndan g\u00fcvenilmektedir.\t\t\t<\/p>\n\t\t\t\t\t<\/blockquote>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-d304be2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"d304be2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-228d25b\" data-id=\"228d25b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0324f79 elementor-widget elementor-widget-image\" data-id=\"0324f79\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/digify.com\/m\/trial?utm_source=blog&#038;utm_medium=article&#038;utm_campaign=footer-trial\" target=\"_blank\" rel=\"noopener\">\n\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"640\" height=\"160\" src=\"https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2-1024x256.png\" class=\"attachment-large size-large wp-image-24512\" alt=\"\u00fccretsiz denemeye ba\u015flay\u0131n\" srcset=\"https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2-1024x256.png 1024w, https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2-300x75.png 300w, https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2-768x192.png 768w, https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2-18x5.png 18w, https:\/\/staging-x.digifyteam.com\/wp-content\/uploads\/2019\/11\/2.png 1200w\" sizes=\"(max-width: 640px) 100vw, 640px\" \/>\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-dca7179 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"dca7179\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-aee7469\" data-id=\"aee7469\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2d8e355 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"2d8e355\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f1b611e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f1b611e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a05010f\" data-id=\"a05010f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4156571 elementor-widget elementor-widget-text-editor\" data-id=\"4156571\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h5>Dipnotlar<\/h5><p>1. Kaynak: Forbes, <a href=\"https:\/\/www.forbes.com\/sites\/neilpatel\/2015\/01\/16\/90-of-startups-will-fail-heres-what-you-need-to-know-about-the-10\/\" target=\"_blank\" rel=\"noopener\"><em>Giri\u015fimlerin 90%'si Ba\u015far\u0131s\u0131z Oluyor: \u0130\u015fte Bilmeniz Gerekenler\u00a0<\/em><\/a><\/p><p>2. Kaynak: BioPharmaDive, <a href=\"https:\/\/www.biopharmadive.com\/news\/venture-capital-biotech-private-funding-first-quarter-2024\/712485\/\" target=\"_blank\" rel=\"noopener\"><em>\u00d6zel biyoteknoloji finansman\u0131, giri\u015fim \u015firketlerinin nakit kullanmas\u0131yla art\u0131yor<\/em><\/a><\/p><p>3. Kaynak: <a href=\"https:\/\/www.ey.com\/en_us\/life-sciences\/biotech-outlook#form\" target=\"_blank\" rel=\"noopener\"><em>EY Biyoteknoloji Raporu 2024\u00a0<\/em><\/a><\/p><p>4. Kaynak: Genetik M\u00fchendisli\u011fi ve Biyoteknoloji Haberleri, <a href=\"https:\/\/www.genengnews.com\/gen-edge\/ai-cell-gene-therapy-precision-medicine-drive-bullish-biotech-investment\/\" target=\"_blank\" rel=\"noopener\"><em>Yapay Zeka, H\u00fccre\/Gen Terapisi ve Hassas T\u0131p Biyoteknoloji Yat\u0131r\u0131mlar\u0131nda Y\u00fckseli\u015fe Yol A\u00e7\u0131yor<\/em><\/a><\/p><p>5. Kaynak: Bio.News, <a href=\"https:\/\/bio.news\/federal-policy\/ip-biotech-world-intellectual-property-day-leadership-innovation\/\" target=\"_blank\" rel=\"noopener\"><em>ABD'nin biyoteknoloji alan\u0131ndaki liderli\u011fi g\u00fc\u00e7l\u00fc fikri m\u00fclkiyet korumas\u0131na dayan\u0131yor<\/em><\/a><\/p><p>6. Kaynak: Life Sci VC, <a href=\"https:\/\/lifescivc.com\/2017\/07\/distinctive-biotech-corporate-culture-walk-talk\/\" target=\"_blank\" rel=\"noopener\"><em>Ay\u0131rt Edici Biyoteknoloji Kurum K\u00fclt\u00fcr\u00fc: Konu\u015fmay\u0131 Y\u00fcr\u00fct<\/em><\/a><\/p><p>7. Kaynak: The Record, <a href=\"https:\/\/therecord.media\/clinical-test-data-of-enzio-biochem-stolen\" target=\"_blank\" rel=\"noopener\"><em>Biyoteknoloji \u015firketi Enzo Biochem'den 2,5 milyon ki\u015finin klinik test verileri \u00e7al\u0131nd\u0131<\/em><\/a><\/p><p>8. Kaynak: Moderna, <a href=\"https:\/\/investors.modernatx.com\/news\/news-details\/2023\/Moderna-Announces-Advances-Across-mRNA-Pipeline-and-Provides-Business-Update\/default.aspx\" target=\"_blank\" rel=\"noopener\"><em>Moderna mRNA Boru Hatt\u0131ndaki Geli\u015fmeleri Duyurdu ve \u0130\u015f G\u00fcncellemesi Sa\u011flad\u0131<\/em><\/a><\/p><p>9. Kaynak: Fierce Biotech, <a href=\"https:\/\/www.fiercebiotech.com\/biotech\/biopharma-vc-slips-last-years-q4-and-where-investors-are-likely-place-future-bets-pitchbook\" target=\"_blank\" rel=\"noopener\"><em>Biyofarma VC faaliyeti ge\u00e7en y\u0131l geriledi; ancak \u2018canl\u0131\u2019 molek\u00fcler tutkal pazar\u0131 umut veriyor: PitchBook<\/em><\/a><\/p><p>10. Kaynak: Pitchbook, <a href=\"https:\/\/files.pitchbook.com\/website\/files\/pdf\/H1_2024_VC_Tech_Survey.pdf\" target=\"_blank\" rel=\"noopener\"><em>H1 2024 VC Teknoloji Anketi<\/em><\/a><\/p><p>11. Kaynak: \u0130la\u00e7 Ke\u015ffi ve Geli\u015ftirme, <a href=\"https:\/\/www.drugdiscoverytrends.com\/biotech-funding-landscape-2023\/\" target=\"_blank\" rel=\"noopener\"><em>2023'te k\u00fcresel biyoteknoloji finansman ortam\u0131: Avrupa ve \u00c7in ilerleme kaydederken ABD ba\u015f\u0131 \u00e7ekiyor<\/em><\/a><\/p><p>12. Kaynak: <a href=\"https:\/\/cinea.ec.europa.eu\/programmes\/horizon-europe_en\" target=\"_blank\" rel=\"noopener\"><em>Horizon Avrupa<\/em><\/a><\/p><p>13. Kaynak: \u0130la\u00e7 Ke\u015ffi ve Geli\u015ftirme, <a href=\"https:\/\/www.drugdiscoverytrends.com\/biotech-funding-landscape-2023\/\" target=\"_blank\" rel=\"noopener\"><em>2023'te k\u00fcresel biyoteknoloji finansman ortam\u0131: Avrupa ve \u00c7in ilerleme kaydederken ABD ba\u015f\u0131 \u00e7ekiyor<\/em><\/a><\/p><p>14. Kaynak: Deloitte, <a href=\"https:\/\/www2.deloitte.com\/content\/dam\/Deloitte\/it\/Documents\/life-sciences-health-care\/2024-global-life%20-sciences-sector-outlook.pdf\" target=\"_blank\" rel=\"noopener\"><em>2024 K\u00fcresel Ya\u015fam Bilimleri<\/em><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Biyoteknoloji \u015firketlerinin geli\u015fen bir ortamda veri g\u00fcvenli\u011fine \u00f6ncelik verirken kaynak yaratma zorluklar\u0131n\u0131 nas\u0131l a\u015fabileceklerini ke\u015ffedin.<\/p>","protected":false},"author":5,"featured_media":24458,"comment_status":"closed","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"footnotes":""},"categories":[29],"tags":[30],"class_list":["post-24305","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-fundraising"],"_links":{"self":[{"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/posts\/24305","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/comments?post=24305"}],"version-history":[{"count":10,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/posts\/24305\/revisions"}],"predecessor-version":[{"id":38947,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/posts\/24305\/revisions\/38947"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/media\/24458"}],"wp:attachment":[{"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/media?parent=24305"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/categories?post=24305"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging-x.digifyteam.com\/tr\/wp-json\/wp\/v2\/tags?post=24305"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}